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ABSTRACT
APPLICATION OF RAMAN SPECTROSCOPY IN PHARMACEUTICALS
by
Anna Żarów
Experimental research on the use of Raman spectroscopy as an in- and on-line sensing
tool and a complementary characterization technique for pharmaceutical applications is
presented in this thesis. In the first chapter following a broad overview, the use of Raman
spectroscopy, together with x-ray powder diffraction, scanning electron microscopy
(SEM) and differential scanning calorimetry, for multilevel characterization of
cryomilled powders, and the melt-grown amorphous phase of griseofulvin, a model
active pharmaceutical ingredient (API), is presented and discussed in detail. A key
feature was the observation of a broad inelastic background superimposed on the Raman
spectra of cryomilled powders, which is attributed to lattice disorder and Mie scattering
generated by mechanical processing and sub-micron particle interfaces. In the following
chapter, polymorphs of another model API, acetaminophen (APAP), were studied by
Raman spectroscopy with supporting information obtained from x-ray diffraction, SEM
images and intrinsic dissolution profiles. An important result was the stabilization and
characterization of the metastable type II orthorhombic phase of APAP which is highly
desired for its unique tabletting properties which are important for pharmaceutical
manufacturing. Stabilization of metastable type II APAP was achieved by micronizing or
nanocoating stable monoclinic crystallites of type I APAP. In addition, as an Appendix to
the thesis, micro-Raman spectroscopy of single crystal APAP as a function of crystal
orientation and of temperature was measured to provide an understanding of the lattice
properties of APAP for input into models to predict its behavior under mechanical

milling conditions widely used in pharmaceutical processing. Molecular behavior
obtained from the above studies guided simulated in-line and off-line characterization of
griseofulvin as thin gel films made from micronized powders and nanosuspensions. By
employing complementary near infrared and Raman imaging for newly developed films,
it was possible to extract valuable information on the spatial distribution and crystallinity
of the embedded particles in a polymeric matrix at different scales of scrutiny.
Chemometrics processing of spectroscopic data for films and nanosuspensions allowed
for qualitative and quantitative particle size determinations of the API’s in the films and
nanosuspensions. In the final chapter a photonic crystal substrate for surface enhanced
Raman spectroscopic (SERS) sensing was employed to detect and study griseofulvin and
APAP down to 10-8 M levels with enhancement factors approaching 109. Detection
sensitivities of the aromatic griseofulvin and APAP molecules were also compared with
those of less aromatic and non-aromatic energetic molecules in order to understand the
Raman enhancement process.
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CHAPTER 1
INTRODUCTION

1.1 General Background
The pharmaceutical industry, as one of the leading industries in the US, has experienced
various challenges in the recent years. The number of drugs coming off patents and
increase in generic drug availability is putting tremendous price pressure on domestic
companies and their products. Quality issues are also at stake as the high number of
recent recalls has severely damaged the reputation and reliability of the pharmaceutical
industry. The need to increase the quality of the products due to numbers of recalls
resulted in development of the Process Analytical Technology (PAT) initiative proposed
by the US Food and Drug Administration (FDA). This initiative, which was first created
in 2004 as an advisory for industry, will soon change into requirements to be adopted and
followed.
Defined by the FDA, PAT is “a system for designing, analysis, and controlling
manufacturing through timely measurements (i.e., during processing) of critical quality
and performance attributes of raw and in-process materials and processes with the goal of
ensuring final product quality” [1]. Real time process control is a critical aspect of the
PAT initiative especially since nanotechnology becomes a part of novel and innovative
pharmaceutical products. Process understanding and process control, robust design and
built-in quality need to be integrated along the way at each stage of the manufacturing
process to minimize widely used end-product or batch-to-batch testing. By implementing
PAT, assessment of critical quality attributes of materials and products can be determined
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early in the process development and allow for improvements and design of wellunderstood methodologies, ensuring high product quality throughout the continuous
manufacturing process. Many analytical techniques are already used as in-process quality
control tools, which includes a variety of physical techniques, such as diffraction,
thermal, and spectroscopic methods applicable for macro-, micron- and sub-micron scale
characterization. Used for solid state analysis, the analytical techniques provide
understanding and knowledge on many complex phenomena at the molecular level (for
example, polymorphism, disorder and defect-formation in molecular crystals, and
chemical reactions), and at the batch-to-batch level during manufacturing (such as,
granulation, drying and powder blending). To fully execute the FDA’s PATs philosophy,
these methodologies will require tools capable of operating at-line, on-line, and in-line
stages and effectively utilize data processing management systems at all aspects of
pharmaceutical development. Operating stages for the monitoring of manufacturing
processes are presented in Figure 1.1 where the in-line analysis is shown to be performed
at no physical contact between analytical system and the sample as the analyzer is located
within the process. On-line analysis requires automated sampling and transfer to the
automated analyzer. For at-line characterization, sampling is performed manually and
transported to the analyzer located in the manufacturing area whereas in case of off-line
analysis, the analyzer is located in the off-line laboratory.
Vibrational spectroscopy, for example near-infrared (NIR) and Raman
spectroscopy, has gained wide acceptance as fast, highly informative and non-destructive
complementary methods for this purpose. These technologies can be placed at many
interfaces of pharmaceutical processes to provide rapid, non-invasive real-time data.
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Figure 1.1 Pharmaceutical processes monitoring [2].
Raman spectroscopy plays a significant analytical role in molecular level process
understanding in the pharmaceutical industry. Process and bench-top applications have
been developed using Raman spectroscopy and can be applied for qualitative and
quantitative process evaluation.

Successful Raman spectroscopy applications in the

pharmaceutical field include blend uniformity, reaction monitoring, solid quantification,
coating monitoring and probably most significantly, crystallization monitoring and
polymorph detection and analysis [3]. Significant technological development in the area
of instrumentation has allowed the implementation of fiber optics, immersion and big
spot size probes, and dispersive components into Raman systems, making them highly
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robust and versatile tools for on-line and off-line characterization in the pharmaceutical
industry [4].
This thesis, focused on the use of Raman spectroscopy as a characterization and
sensing tool was part of a large effort supported by a National Science Foundation (NSF)
funded Engineering Research Center (ERC) for Structured Organic Particulate Systems
involving Rutgers University (lead), Purdue University, New Jersey Institute of
Technology and the University of Puerto Rico at Mayaguez. The overall goal of the ERC
was a national focal point for innovative science-based development of structured organic
composite products and their manufacturing processes in the pharmaceutical industry.
Work performed in this thesis was part of two projects within the ERC, one involving
sensing for effective manufacturing and the other multilevel characterization of the
composite products produced.
In this introductory chapter, the following sections will discuss the fundamentals
of Raman spectroscopy in terms of its scientific background, instrumentation and
techniques used in pharmaceutical research. Further, concepts of phase transitions in
molecular crystals, the definition of the long- and short- range order in the solid state, and
consequently

the

benefit

of

using

the

Raman

technique

to

monitor

crystallization/amorphization processes, will be discussed. The differences between
Raman and fluorescence spectroscopy will also be illustrated. Other characterization
techniques, such as Scanning Electron Microscopy (SEM), X-Ray Diffraction (XRD),
and Differential Scanning Calorimetry (DCS) will be briefly introduced as they will be
employed throughout this work to support the Raman spectroscopic data.
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1.2 Raman Spectroscopy
1.2.1

The Raman Effect

In 1928, Sir Chandrasekhara Venkata Raman along with his colleague, Kariamanickam
Srinivasa Krishnan, discovered “a new type of secondary radiation” [5] in sixty different
common liquids. They observed a shift in the color of light scattered to some degree in
most of the liquids simply by probing the samples with concentrated sun light. For this
discovery, C. V. Raman was awarded the Nobel Prize in Physics in 1930 and the
phenomenon that described the inelastic exchange of energy between light and matter
was later named the Raman Effect.
When light interacts with matter, it can be either absorbed or scattered. During the
scattering process, the majority of the light is scattered elastically at the same frequency
and with no energy transfer between light and the molecule or solid. This is known as
Rayleigh scattering. However, when the oscillating electric field of the incoming
radiation interacts with molecules or the solid, there is also a small but finite possibility
of the molecule or solid retaining the incoming photon’s energy and generating
vibrational excitations. This interaction is known as inelastic scattering of light or
spontaneous Raman scattering when the interaction is non-resonant. The phenomenon is
a low probability event and only 1 out of 107 photons will undergo inelastic scattering.
During the interaction, the energy carried by incoming photons excites vibrational states
within a molecule or a solid by distorting the electron clouds around molecular or
intermolecular bonds in a solid. This shift in electron cloud distribution results in a
change in bond polarizability (α) and induces a temporary dipole moment (P) and excites
the molecule or solid into a virtual excited state when the interaction is non-resonant.
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Since excited states do not have infinite lifetime, the scattering events occur in 10-12
seconds or less [6] after which the molecule or solid relaxes back to its ground state,
emitting a photon at a specific frequency (ννib).
Depending on the energy difference between the original and the relaxed states,
there is a change in the frequency of the emitted light from that of the incident light.
Molecules or solids that relax back to the pre-excited state emit the same frequency (ν)
light to give rise to elastic scattering. Molecules or solids that relax to a different

vibrational state, however, emit a photon of different energy to give rise to inelastic
scattering. This generated photon is shifted in frequency by an amount corresponding to
the energy of a particular vibrational transition. If the final state is more energetic than
the initial state, the emitted photon will be shifted to a lower energy (ν-ννib) which is
designated as a Stokes shift. If the final state is less energetic, the emitted photon will be
shifted to a higher frequency (ν+ννib) resulting in an anti-Stokes shift as shown in Figure
1.2. Such a change in energy gives rise to inelastic scattering of photons. The energy
difference corresponds to a vibrational or rotational (librational in the case of solids)
frequency of a molecule within gaseous, liquid and solid states, or of vibrations between
molecules or ions in a solid, and is referred to as the Raman Effect.
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Figure 1.2 Rayleigh, Raman Stokes and anti-Stokes scattering, and fluorescence energylevel diagram.

The theory behind the Raman effect was derived by Austrian physicist, Adolf
Smekal, five years prior to its discovery by C. V. Raman, who predicted the existence of
stray lines with shifted frequencies [7]. Mathematical representation of Raman scattering
can be expressed in terms of induced dipole moment in a diatomic molecule. The strength
of the induced dipole moment (P) depends on the electrical field (E) of the incident
electromagnetic radiation:
P = αE

(1.1)

where α is the polarizability tensor of the molecule that measures the ease with which the
electron charge cloud around the molecular bond is distorted. Considering the molecule
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in the external electric field in terms of wave mechanics, one finds that the induced dipole
moment is given by [6]:
P = α0E0cos(2πνt) +

Rayleigh

1   
1   

 q0E0cos(2π(ν+ννib)t) + 
 q0E0cos(2π(ν-ννib)t)
2  q 0
2  q 0

anti-Stokes

(1.2)

Stokes

  

 - Rate of change of α with respect to the change in q at equilibrium position

q

0

The first term represents an oscillating dipole that elastically scatters the light of
frequency (ν) corresponding to Rayleigh scattering. Induced dipole moments are created
at distinct anti-Stokes (ν+ννib) and Stokes (ν-ννib) frequencies to give rise to inelastic
scattered radiation at these frequencies. The necessary condition for Raman scattering to
occur requires the bond polarizability to change as a function of bond length variation
  
 which is nonduring the vibration. This is given by the polarizability derivative, 
 q 0

zero for a Raman-active vibration.
1.2.2

Raman Instrumentation and Techniques

Raman spectrometers can be either dispersive (for light sources in the visible and nearinfrared range) or interferometer systems (for light sources in the infrared range). Most
commonly used systems are dispersive and consist of a notch or edge filter for rejection
of Rayleigh scattering, a monochromator for dispersion of the scattered radiation and a
charge coupled device (CCD) array for photon detection as depicted in Figure 1.3 (a).
The sample is excited with a laser source in the ultraviolet (UV), visible (Vis) or near
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infrared (NIR) range, passed through a notch filter or monochromator to eliminate the
intense Rayleigh scattering. The Raman resulting signal is then sent via a grating
spectrometer to a CCD detector.

(a)

Sample

(b)

Laser

Notch Filter or
Monochromator

Pinhole

CCD Detector

Excitation
Laser Beam
Beam-splitter

Object
Single Grating
(Spectrometer)
Spectrum

Sample Focus
Plane

Figure 1.3 Raman spectrometers in: (a) Fiber optic and (b) Confocal geometries.
Raman sampling is a fast process and requires only a few seconds for a spectrum
to be acquired to provide a wealth of information concerning the chemical composition
and structure of the probed region. Optical fibers allow for remote or stand-off sample
sensing since both the laser and scattered light travel through the same fiber optic probe.
A micro-Raman spectrometer, although not designed for remote sampling, couples the
spectrometer and incident light source to an optical microscope, thus allowing Raman
analysis with a microscopic laser spot size which is ideal for probing micron to submicron scale sample features.
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The sub-micron spatial resolution achieved by a Raman microscope allows for
analysis of the solid state structure, and the spatial distribution of polymorphs and active
particles in a composite. Combining the micro-Raman analysis with an automated stage
allows the creation of a chemical map of a composite sample [8]. During mapping, a
complete Raman spectrum is obtained for each pixel of the image and since each
spectrum represents the fingerprint of a chemical species, the distribution of different
materials and/or their local properties can be analyzed. By placing a small confocal
pinhole in the focal plane of the microscope as indicated in Figure 1.3 (b), axial
resolution can be further improved by allowing collection of spectra from a sample
volume and creating depth profile of a sectioned specimen [9, 10].
In Fourier Transform (FT)-Raman spectroscopy an interferometer is used to
produce an interferogram to encode the unique frequencies of the Raman spectrum into a
single signal. The advantage of FT-Raman spectroscopy is mostly due to the use of an
infrared laser (typically at 1064 nm) as the excitation source which minimizes the laserinduced fluorescence in the sample that can interfere with the weak Raman signal.
Several types of Raman spectroscopy have been developed to enhanced its sensitivity
and improve spatial resolution. In this thesis, Surface Enhanced Raman Spectroscopy
(SERS) will be discussed as a technique for improved detection limits through
enhancement of the Raman signal from Raman-active analyte molecules adsorbed on
gold coated photonic crystal-type arrays. The enhancement of the weak Raman signal by
SERS relates primarily to two mechanisms: an electromagnetic enhancement induced by
coupling to surface plasmons and a chemically-induced enhancement [11]. Chapter 5 will
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discuss is some detail the basic principles behind SERS and illustrate its applications for
rapid trace detection of pharmaceuticals and related organic molecules.

1.2.3 Raman Effect in Relation to Structural Disorder, Phase Transitions, and
Particle Size
Modern Raman spectroscopy uses laser light sources to generate elastic and inelastic
scattering to obtain vibrational spectroscopic information about molecules and solids.
The so-called spectral fingerprint region in the 700 to 1900 cm-1 frequency range contains
information about the frequencies or energies of key molecular vibrations. In addition,
information about molecular rotations, and translations and hindered rotations (or
librations) in a solid, is obtained from spectra below 200 cm-1. The vibrational energies or
frequencies depend on the mass of particular atoms in a molecule or an ion in an ionic
solid, the nature of the chemical bonds connecting them, the symmetry of the molecular
structure in a gas or liquid, and the local structure of the environment where they reside
in a crystalline solid (Figure 1.4).

(a)

(b)

(c)

Figure 1.4 Schematic depictions of three types of order in a solid: (a) A periodic array
with long-range order as in a crystalline solid; (b) A periodic array in a defected solid
with short-range order, and (c) An amorphous solid.
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Crystalline solids are composed of atoms/molecules or ions arranged in periodically
repeating unit cells. This order, which is of long-range in bulk solids is linked to their
optical, electrical, magnetic and mechanical properties. X-ray powder diffraction (XRPD)
is routinely used to determine the crystallinity and average particle size in polycrystalline
powders. However, many imperfections reside at short ranges which can be overlooked
by XRPD. Among the most common imperfections in the crystalline lattice are point,
linear, and planar defects that occur naturally in many materials [12] and can also be
induced by mechanical processing via stress-induced perturbations. Induced disorder or
defects at short range can propagate through the solid to give rise to longer range disorder
or amorphization. Raman spectroscopy can provide information on structural variations
at the molecular, short range scale and on crystallite sizes below the quantum localization
limit through change of the intensities, frequencies, and linewidths of characteristic
Raman lines. Moreover, decrease in line intensities can occur due to increased sizes of
particles in a suspension because of decreased light throughput or increase diffuse
reflectance [13]. This methodology can be used to determine the average particle size online in a suspension from calibration curves obtained on control samples using light
scattering methods.
The Raman spectrum provides key structural information at various frequency ranges.
It determines intra- and inter- molecular vibrations that correspond to different frequency
ranges as depicted in Figure 1.5. In the crystalline state, it is involved with both
molecular and inter-molecular translational and hindered molecular rotational or
librational vibrations. In the solid state, the Raman-active vibrations are small wave
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vector (k=2/, where  is the wavelength) optical phonons, which are quantized
collective vibrational excitations superimposed on each other as plane waves and
propagating throughout an individual crystal. These vibrations are grouped into
molecular vibrations that involve

stretching (ν), bending (δ), and torsional (τ)

oscillations, and lattice vibrations consisting of librational (hindered rotational) and
translation motions. For compositional identification, molecular modes are typically
Molecular Order
Bending/stretching
modes
Lattice Order
Lattice modes

Molecular C-H
stretching modes

Inelastic Scattering Background – structural disorder

Figure 1.5 The Raman spectrum of a typical organic solid and the broad inelastic
scattering background component associated with structural disorder. Information
obtained from the data is also indicated.
studied since they are most sensitive to bond length and symmetry changes, and
substitution of atoms, therefore giving information about the molecular structures
involved [14].
Lattice modes are sensitive to the structural arrangement of the solid since they
correspond to relative motions of the molecular units or ions in a unit cell of the lattice
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[15]. These motions are categorized based on the direction in which the neighboring
atoms oscillate. For Raman-active optical phonons, the vibrations correspond to
transverse oscillations whereas acoustic phonons that are observed optically by Brillouin
scattering at low k and at higher k by neutron scattering, oscillate longitudinally.
The total number of phonons propagating in a primitive crystal containing N unit
cells each with p atoms is given by 3pN-6 (where the number of acoustic and optical
modes is 3 and 3pN-3, respectively). The corresponding wave vectors (k) belong to a
volume of reciprocal space referred to as the Brillouin zone (BZ) [16]. Raman-active
optical phonons in a crystalline solid occur at k0. However with decreasing crystallite
size down to the amorphous level where long range order is lost, this rule is no longer
valid and all phonons contribute to Raman scattering resulting in broad lines, frequency
shifts and line asymmetry [17]. In the nanocrystalline phase, however, the situation is
somewhat intermediate and the Raman spectrum displays broadened crystalline features
which are shifted due to phonon confinement at the nanoscale [17, 18]. In addition, the
symmetry of bulk crystalline materials can be broken in nano-crystals due to the high
concentration of grain boundaries (coincident lattices), which also causes the appearance
of specific surface modes as reported for silicon by Veprek et al [18]. In the case of
nanocrystalline silicon it is found that below 3 nm a discontinuous transition to the
amorphous phase occurs [16-18].
Raman spectroscopy is widely used for qualitative and quantitative characterization
of polymorphs; it is also used to determine particle sizes in suspensions via changes in
line intensity, crystal quality by monitoring linewidth and stress or strain by monitoring
line frequencies (Figure 1.6). By definition, a polymorph is a crystal that can exist in two
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or more crystalline phases, each having different crystal structures [19]. Phase
identification is important because the material properties are highly dependent on
structure. Raman spectra of polymorphs show changes in vibrational frequencies mainly
because of different molecular and crystal symmetries in each polymorph due to changes
in inter-molecular interactions influence the vibrational energies of each crystal structure.
Amorphous forms loose long range order and give rise to broad lattice mode Raman
(a)

(b)

(c)

(d)

Figure 1.6 Changes in Raman lines due to: (a) Polymorphism – change in Raman peak
frequencies, (b) Amount of material – change in intensity of Raman line, (c) Quality of
crystal – change in Raman linewidth, (d) Application of stress or strain state – change in
Raman line frequency.
spectra, although Raman lines due to molecular modes in the amorphous phase of organic
crystals broaden but remain discrete since the molecules themselves are largely
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unchanged. Intrinsically, spectral linewidths are inversely proportional to the lifetime of
an excited state following the Heisenberg Uncertainty Principle [20]. Therefore, in bulk,
highly crystalline solids, the excited states are long-lived and give rise to spectra with
small linewidths. For example, by taking a Raman excited state lifetime of 10-12 seconds
for single crystal silicon, the calculated peak width is 5 cm-1, which is in agreement with
the experimentally measured values for Raman scattering from single-crystal Si by
Parker et al [20]. The phenomenon of phase transitions will be discussed further in
Chapter 3.
Characterization at the Raman level as described above can provide better
pharmaceutical products with innovative technologies involving drugs with nanotechnological input. In order to build quality into these novel drugs, one therefore needs
to have a thorough understanding of the material’s behavior during manufacturing
processes (including mechanical and chemical changes) and this is a critical aspect for
building better quality products.
1.2.4

Distinguishing Raman Scattering from Fluorescence

The intensity of the Raman signal is proportional to the 4th power of the excitation
frequency. Short excitation laser wavelengths deliver highly intense Raman signals; for
example, exciting a sample with blue light (400 nm) will give a Raman signal that is 16
times stronger than that obtained using red light at 800 nm. However, when using laser
excitation wavelengths below 600 nm results in intense first order fluorescence from the
samples.
Raman scattering, which is a weak effect, is often overshadowed by fluorescence
emission from the sample arising from competing phenomena with similar origins but
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higher cross-sections. In Raman spectroscopy, the laser photon interacts with a molecule
in its ground electronic state with and without thermal excitation to gain (the anti-Stokes
process) and lose (the Stokes process), respectively, a certain amount of energy
corresponding to a vibrational frequency of the molecule via a virtual excited electronic
state. The various frequency shifts associated with different atomic vibrations in the
molecule give rise to a Raman spectrum that is unique for a specific molecule. The
Stokes spectrum is typically more intense than the anti-Stokes spectrum because a
smaller fraction of the molecules are thermally excited at room temperature.
In spontaneous, non-resonant Raman spectroscopy, the interaction of the photon
and its re-emission occurs almost instantaneously (10-12 seconds or less) after excitation
to a virtual excited state of the molecule followed by relaxation to vibrational states of the
ground electronic level to generate a Raman spectrum on the higher (anti-Stokes) and
lower (Stokes) energy side of the elastic Rayleigh scattering. The spectrum comprises of
narrow emission lines associated with the vibrational modes of the molecule. The intense
Rayleigh scattering is filtered out by a single or double monochromator, coupled to an
optical notch filter. In contrast, fluorescence emission takes place by an absorption
process to real electronic energy levels of the molecule followed by rapid relaxation from
electronic and vibrational states down to the excited vibrational levels of the ground state
as in Raman scattering. Therefore although the mechanism is different, the net result of
both processes is essentially the same and in both cases a photon of energy with the
frequency different from that of the incident photon is released by bringing the molecule
to a higher or lower energy level. In fluorescence, the photon energy is absorbed by the
molecular species from its ground electronic state to one of the various vibrational states
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in the excited electronic state as shown in Figure 1.2. Following this, collisions with other
molecules cause the excited molecule to lose vibrational energy until it reaches the lowest
vibrational state of the excited electronic state. The molecule then drops down again to
one of the various vibrational levels of the ground electronic state, emitting a photon in
the process. Since the molecules can drop down into any of several vibrational levels in
the ground state, the emitted photons will give rise to a broad envelope of different
energies or frequencies. The lifetime of the excited state is much longer (ca. 10-8 to 10-5
seconds) [6] from which the molecule relaxes into various lower energy states, to produce
the fluorescence spectrum. This results in high intensity, but lower chemical specificity
because a broad envelope of energies is emitted. Moreover, fluorescence involves a
resonant process between real electronic states and is therefore strongly dependent on the
frequency or wavelength of the incident light [21]. The Raman effect on the other hand is
typically spontaneous and excitation wavelength independent. It is a relatively weak
process involving virtual states mediated by the molecular vibrations and associated with
change in bond polarizability.

1.3 Other Characterization Techniques
Although the focus of this work is primarily on the use of Raman spectroscopy to
characterize and study pharmaceutical powders, films and suspensions, other advanced
analytical and imaging tools were also employed throughout this research. In the
pharmaceutical industry these advanced methods are often used concomitantly in order to
overcome the complex challenges of data interpretation and provide a more complete
picture of the solid-state. This approach has also been employed in this research since
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solid-state analysis requires more than one technique for effective analysis.

In the

following sub-sections, some of the techniques used will be briefly discussed while
others will be considered in more detail in some of the following chapters.
1.3.1

Scanning Electron Microscopy (SEM)

Scanning Electron Microscopy (SEM) involves a high resolution microscope that uses a
high-energy beam of electrons instead of light to form an image. This technique allows
for physical characterization of the material surface as the signal results for the electron’s
interaction with the atoms at the sample surface. Since the magnetically focused beam of
electrons is very narrow, SEM records microscale to nanoscale images with large depth
of field, resulting in a three-dimensional appearance with spatial resolution on the order
of 5 nm in the best microscopes. Physical characteristics, such as particle size, shape, and
morphology of an active pharmaceutical ingredient (API) and associated excipients are
important for pharmaceutical process understanding as they can influence the dissolution
profile and drug bioavailability. Typical SEM images provide nanoscale visualization of
the surface structure and morphology of pure and composite solids. Throughout this
research SEM images were obtained with a VP-1530 Carl Zeiss LEO (Peabody, MA)
field emission scanning electron microscope. The samples, which were all nonconducting, were mounted on aluminum stubs using double-sided carbon tape and
sputter-coated with carbon to avoid charging.
1.3.2

X-Ray Powder Diffraction

X-Ray Powder Diffraction (XRPD) is a powerful technique that besides phase
identification is largely used for determining the first order crystal structure, average
crystallite size and stress in polycrystalline powders and composites.

The small
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wavelength of X-rays used to probe the sample, typically 1.54Å for CuK radiation in
laboratory instruments, is comparable to inter-atomic distances and therefore gives
structural arrangements of atoms and molecules when single crystal diffraction
techniques are employed. To probe wider ranges in k space using XRPD, a small angle
Synchrotron X-ray light source is used. In this thesis, laboratory scale wide angle XRPD
and small-angle Synchrotron XRPD studies were performed to investigate the effect of
mechanical milling on sample crystallinity and correlate the scale of structural changes
with Raman results. For example, in Chapter 3, XRPD was used to confirm crystallinity
and structure of the newly developed stable phase of acetaminophen.
All samples investigated in this study were analyzed using a wide-angle Philips
X’pert PW3040 X-Ray Diffractiometer with CuKα radiation (λ =1.5406 Å) operated at
40kV and 30mA, with 2θ ranging from 5° to 50°. Temperature-dependent small-angle
Synchrotron X-ray powder diffraction measurements were conducted at the beam line
X10A (λ=1.097Å) with a CCD detector at the National Synchrotron Light Source
(NSLS), Brookhaven National Laboratory on a micronized griseofulvin sample as
discussed in Chapter 2. The data were interpreted using parameters obtained from an
Al2O3 reference.
1.3.3

Differential Scanning Calorimetry (DSC)

Thermal analysis techniques measure the physical stability and phase transitions of drug
products and excipients during heat exposure. In particular, differential scanning
calorimetry (DSC) measures the amount of heat required to increase the sample
temperature in reference to the standard material. For polymorphs, the chemical entity
remains the same but physical properties, such as density, melting point, or heat capacity
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can vary due to different crystal packing from one polymorph to another. DSC is widely
used for the initial detection and quantification of polymorphs since it measures the
enthalpy term, ΔH, associated with the lattice energy difference [22]. In this study, DSC
was performed with a FP900 Thermo System (Mettler-Toledo, Columbus, OH)
comprising of a FP90 Central Processor and FP84HT TA Microscopy Cell. Sample
weights were kept in a range between 6 to 8 mg and were heated at 5°C/minutes to a
temperature exceeding the melting point of griseofulvin at 230°C.

1.4 Summary of Chapters to Follow
After this brief introduction to Raman spectroscopy in Chapter 1, Chapter 2 will discuss a
multilevel characterization approach for processed pharmaceutical powders concentrating
on structural disorder in cryomilled and amorphous griseofulvin. Cryogenic milling used
to reduce particle size of soft crystals was observed also to induce structural disorder in
griseofulvin indicated by broad inelastic Raman scattering and changes in intensities and
splittings of some of the Raman lines with increasing levels of disorder [23]. Chapter 3
will discuss how process design can potentially utilize polymorphs, such as those of
acetaminophen (APAP). The type II polymorph of APAP is metastable but highly
attractive for pharmaceutical applications since it compresses and dissolves better than
the stable type I polymorph. Novel behavior was observed for type II APAP prepared
from milled and nano-coated acetaminophen powders. In addition, an oriented single
crystal study of the behavior of Raman-active APAP vibrations as a function of
temperature will be presented in Appendix A. Under favorable conditions of temperature,
APAP can undergo a phase transition of the stable type I phase into metastable type II,
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highly unstable type III, or even the amorphous type. Temperature-dependent molecular
data of this type coupled with stress-dependent data obtained elsewhere can help generate
predictive models for the behavior of crystallites of active pharmaceutical ingredients
during manufacturing processes.
Applications of Raman spectroscopy as an on-line and in-line sensing tool will be
presented in Chapter 4. They will be combined with off-line results of complementary
Raman mapping and near IR chemical imaging which will be compared and analyzed for
griseofulvin particle distribution, quantification and defect formation in newly developed
polymeric films for pharmaceutical applications [24]. Chapter 5 will finish the thesis by
illustrating the use of SERS phenomena induced by surface plasmon resonance for rapid
trace detection of pharmaceuticals, and related organic molecules used in energetic
formulations [25]. The closing Chapter 6 will provide a broad overview summary of the
results obtained and suggestions for future work.

CHAPTER 2
SPECTROSCOPIC AND X-RAY DIFFRACTION STUDY OF STRUCTURAL
DISORDER IN CRYOMILLED AND AMORPHOUS GRISEOFULVIN

2.1 Objective
Structural disorder induced by cryogenic milling and by heating to the amorphous phase
in the active pharmaceutical ingredient, griseofulvin, has been studied by Raman
spectroscopy, X-ray powder diffraction (XRPD) and fluorescence spectroscopy. A broad,
exciting frequency-independent scattering background in the Raman spectra and changes
in intensities and splitting of some of the Raman lines due to lattice and molecular modes,
have been observed. In the cryomilled samples this strong background is deconvoluted
into two components: one due to lattice disorder induced by cryomilling and the other
due to Mie scattering from nanosized crystallites. A single-component background
scattering attributed to lattice disorder is seen in the Raman spectrum of the amorphous
sample. Fluorescence measurements showed an intrinsic fluorescence signal in asreceived griseofulvin that does not correspond to the inelastic background in the Raman
spectra, and moreover decreases in intensity on cryomilling, thus excluding an
assignment of the Raman background intensity to impurity- or molecular defect- induced
fluorescence. Wide-angle XRPD measurements on cryomilled griseofulvin shows a broad
two-component background consistent with the background scattering component in the
Raman data associated with lattice disorder at longer correlation lengths. Persistence of
this disorder to even longer correlation lengths is evident from small-angle Synchrotron
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XRPD data on micronized griseofulvin, which were taken as a function of temperature as
the sample changes from the crystalline to the amorphous phase.

2.2 Introduction
Milling is widely used by the pharmaceutical industry to reduce the particle size of active
pharmaceutical ingredients (APIs). Size reduction leads to increase in the surface to bulk
ratio of the particle which enhances its bioavailability and dissolution rate. During
milling, however, mechanical stress can induce changes in the crystal lattice of the API
which will modify its physical and chemical properties. Both ball and jet milling,
commonly used by industry, can affect crystal morphology and induce structural disorder
[26]. These changes can cause crystal defects that are believed to mostly exist at the
surface of the crystallites [27] and may originate from molecular conformational changes
or unit cell distortions. Many types of defects exist and the most common ones include
those due to varying grain sizes, edge dislocations and grain boundary effects [28].
Crystalline defects act as higher energy sites that are thermodynamically unstable
compared to those in the stable crystalline form. Defects can progressively transform
during processing into longer range disorder in atomic positions resulting eventually in
the formation of an amorphous phase or a polymorph [29].
Raman spectroscopy is particularly sensitive to structural changes, see Chapter 1.
The first order lattice or inter-molecular modes observed in Raman spectra typically
occur at frequencies below 200 cm-1 [30, 31]. Lattice modes include translational and
librational vibrations that are very sensitive to structural disorder and polymorphism.
Intra-molecular deformation, rocking wagging, breathing and stretching modes which
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typically lie in the frequency range above 200 cm-1 [32] are also sensitive to changes in
the local crystal field caused by disorder or polymorph formation [33]. Therefore,
changes in peak positions and intensities or the appearance of new lines in the Raman
spectra would indicate the formation of defects or disorder, an amorphous phase or a new
structural polymorph [34-36]. In addition, structural defects or disorder in the crystal may
generate background scattering in the Raman spectra and diffuse scattering superimposed
on X-ray diffraction patterns that resemble X-ray scattering from amorphous solids [18,
37-39]. Background intensity in Raman spectra is often caused by fluorescence when the
excitation wavelength is close to an intrinsic electronic transition in the sample or it is
caused by impurities introduced during processing or sample preparation. In both these
cases the background intensity would vary with the excitation wavelength used. If the
scattering background is excitation frequency-independent it may be attributed to other
possibilities, especially if the material had undergone mechanical processing that can
produce structural defects or disorder.
In the present study, cryomilled griseofulvin was investigated for defect and
disorder formation and structural stability using spontaneous Raman scattering and X-ray
powder diffraction (XRPD) techniques. Prior work by Bates et al [37] and Yamamura et
al [38] focused primarily on x-ray diffraction studies of disorder in organic crystal
systems, whereas Veprek et al [18] investigated the transition to the amorphous phase in
silicon, a covalently bonded inorganic crystal, using both x-ray diffraction and Raman
spectroscopy. In this paper, Raman spectroscopic and diffuse inelastic light scattering
data have been obtained and correlated with x-ray diffraction and scattering data obtained
from polycrystalline samples of as-received and processed griseofulvin, an organic solid,
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and from amorphous griseofulvin. Quantitative estimates of crystallinity and particle
sizes were obtained by differential scanning calorimetry (DSC) and from scanning
electron microscope (SEM) images, respectively. The Raman spectra were examined
using two different Raman instruments with different excitation wavelengths in order to
rule out fluorescence and other extraneous effects in the data. Fluorescence spectroscopy,
and wide-angle XRPD and small-angle XRPD using a Synchrotron source were also
conducted. Laser and high humidity annealing experiments were performed to understand
the nature of the defects and disorder induced by cryomilling. In laser annealing, heat is
applied locally to form a thin solid-liquid interface not commonly formed in bulk thermal
treatment. Laser annealing using rastering and broadening of the laser beam is therefore
capable of rapidly removing defects and disorder [39]. The overall objective of the
present work is to develop fast and non-destructive characterization of APIs like
griseofulvin to detect mechanically-induced defects or disorder which could initiate the
growth of undesirable polymorphic forms [40-42].

2.3 Experimental Materials and Methods
2.3.1

Materials

Crystalline Griseofulvin: Obtained from Sigma-Aldrich (St. Louis, MO) and stored at
0ºC in a freezer. Commercially available micronized griseofulvin, USP grade, was
purchased from Spectrum Chemical (Gardena, CA) and also stored at 0ºC in a freezer.
Cryomilled Griseofulvin: Samples of cryomilled griseofulvin were prepared using
cryogenic milling which was performed with a SPEX CertiPrep 6750 cryogenic impact
mill (Metuchen, NJ) as described in reference [34]. The mill consisted of a cylindrical
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vessel made out of polycarbonate within which a stainless steel rod was vibrated by
means of an oscillating magnetic field. Liquid nitrogen was used to pre-cool 2 g of
crystalline griseofulvin. After pre-cooling, the sample was milled in five cycles of 2
minutes milling and 2 minutes cooling. This milling process was repeated three times.
Upon completion, the cryomilled material was placed in a cold water bath for around 10
minutes until it reached room temperature. It was then stored in a desiccator at 0oC. Three
cryomilled samples, referred to as samples 1, 2 and 3 in the text were prepared under
these conditions.
Amorphous Griseofulvin: Two amorphous griseofulvin samples were prepared for this
study, one from crystalline Sigma-Aldrich griseofulvin and the other from cryomilled
griseofulvin. To obtain the amorphous form, small amounts of each sample were placed
on a glass slide, heated on a hot plate at 220ºC (slightly above the melting point of
218ºC) until completely melted and then allowed to cool rapidly to room temperature to
form a clear solidified film on the glass slide. Raman spectra were run immediately after
preparation of the amorphous samples. The appearance of a strong peak at 656 cm-1 in the
Raman spectra was used to confirm the formation of amorphous griseofulvin.
2.3.2

Methods

Raman Spectroscopy: Two different Raman instruments were used to collect Raman
spectra: (a) A confocal Horiba- Jobin Yvon LabRam micro-Raman spectrometer with a
20 mW He-Ne laser source emitting at a wavelength of 632.8 nm focused to a spot size of
10 µm with a 10x lens; and (b) A Mesophotonics SE (Southampton, UK) 1000 Raman
spectrometer calibrated to 2 cm-1 with a 250 mW near-infrared laser operating at 785 nm
with a 130 µm diameter spot size.
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Typical acquisition time for all spectra recorded was 10 sec per scanned spectrum.
Each spectrum acquired using the Horiba-Jobin Yvon LabRam micro-Raman
spectrometer was averaged over 2 scans. Data acquired with the Mesophotonics SE 1000
Raman spectrometer represent an average of 5 scans, for a total of 50 seconds. All Raman
data shown are as-recorded by the instruments used. During spectral acquisition, powder
samples were placed on glass substrates, whereas amorphous samples were both prepared
and analyzed on glass substrates.
Spectral Deconvolution: The inelastic scattering Raman background and diffuse X-ray
scattering background were fitted using a multi-peak fitting package provided in IGOR
Pro software from WaveMetrics, Inc. (Lake Oswego, OR). Deconvolution was performed
using both Lorentzian and Gaussian functions.
Annealing Procedures: The annealing of cryomilled griseofulvin samples was
performed using two different methods – laser irradiation and exposure to high humidity
conditions. The effects of the annealing were then monitored by Raman spectroscopy.
Laser annealing was performed using 20 mW of focused 632.8 nm radiation from a HeNe laser in the Horiba-Jobin Yvon LabRam micro-Raman spectrometer. Each sample
was exposed to constant laser radiation for a total of 30 minutes, with spectra being
obtained periodically. The initial spectrum was recorded prior to the laser treatment and
the final spectrum was recorded upon completion of laser exposure.
Samples for monitoring the effect of high humidity were placed in a sealed
desiccator along with a beaker containing approximately 50 mL of boiling hot de-ionized
water and a humidity meter from Taylor Indoor Humidiguide (Las Cruces, NM).
Humidity levels were maintained at 70-80% and the water was boiled again whenever the
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humidity level dropped below 70%. The temperature was maintained between 21 - 23°C.
Small amounts of sample were removed periodically for Raman measurements using the
Mesophotonics SE 1000 Spectrometer and were disposed of after each measurement.
X-Ray Powder Diffraction: See Chapter 1 for wide-angle Philips X’pert PW3040 XRay

Diffractiometer

and

small-angle

Synchrotron

X-ray

powder

diffraction

measurements details.
Scanning Electron Microscopy (SEM): See Chapter 1 for details.
Differential Scanning Calorimetry (DSC): See Chapter 1 for details.
Fluorescence and UV-Vis Spectroscopy: Solid state fluorescence spectra were acquired
at room temperature using a Hitachi F-3010 Fluorescence spectrophotometer
(Schaumburg, IL) with a Xe lamp. The spectra were measured at a 60 cm-1/minutes
spectral rate and excitation wavelength (λex) of 300 nm. The UV-Visible absorption
spectrum corrected for the solvent signal was acquired with a Varian Cary 50 Bio UVVisible spectrophotometer (Palo Alto, CA) using a 3 ppm solution of griseofulvin in
acetone in a 3 ml quartz cuvette.
2.4 Results and Discussion
2.4.1

Scanning Electron Microscopy

Because particle size and shape can affect the Raman and XRPD data obtained, SEM
imaging of the different griseofulvin samples were carried out. Representative SEM
images from as-received micronized and cryomilled griseofulvin sample no. 3 used in
this study are shown in Figures 2.1 (a) and (b), respectively. Reduction in crystallite sizes
from the breakup of the rod-like particles in the micronized sample can be seen on
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comparing the images. For example, the arrowed regions show fine grains in the
nanometer size range for the cryomilled sample.
2.4.2

Raman Spectra of Crystalline, Cryomilled and Amorphous Griseofulvin

Crystalline molecular solids, such as griseofulvin, have the molecules organized in stable
low energy conformations and in periodic arrays to produce an ordered lattice with interand intra-molecular vibrations which interact with light to give rise to well-resolved
Raman spectra. This highly ordered structure can change under processing or high
temperature conditions to a new crystalline structure, a defected or partially disordered
(a)

(b)

Figure 2.1 SEM images at a magnification of 100,000 of griseofulvin samples used.
Panel (a) shows a typical image for commercially micronized griseofulvin and panel (b)
show an image for cryomilled griseofulvin. Arrows indicate nano-sized grains in the
cryomilled sample.
version of the structure, or an amorphous solid where the molecules are oriented in a
random fashion while still maintaining their original stable conformation or a new
conformation stabilized in the newly disordered lattice potential. The inter-molecular
lattice modes of the crystalline phase are replaced by large amplitude diffusive or
relaxational modes in the amorphous phase [43]. The lattice mode Raman lines of the
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crystals broaden substantially in the amorphous phase whereas the intra-molecular
vibrational lines remain largely unchanged if there is no change in molecular
conformation. Typically, however, there are changes in molecular conformation and
inter-molecular hydrogen bonding interactions in the amorphous phase and in
polymorphs, resulting in shifts in line frequencies, linewidth broadening and changes in
line intensities. In the case of a defected structure, the Raman spectrum will depend on
the nature of the defects formed. Localized molecular defects would give rise to new
lines in the molecular vibration frequency region coupled with excitation wavelength
dependent fluorescence superimposed on the Raman spectrum as a broad signal. Crystal
defects, such as dislocations and orientational defects of the type discussed by Feng et al
[34] will most likely occur at grain boundaries created by milling. These defects give rise
to longer range disorder manifested as a scattering background in the XRPD data,
whereas shorter range disordered domains will give rise to a broad inelastic scattering
background in the Raman spectra [15, 44]. These aspects of the Raman spectra and
XRPD data from Griseofulvin will be discussed below. Milling-induced reduction in
crystallite size to dimensions comparable to that of the Raman excitation wavelength can
in addition give rise to excitation frequency independent Mie scattering superimposed on
the Raman spectrum as discussed by Kiefer [45].
The Raman spectra of crystalline, cryomilled and amorphous griseofulvin
obtained with 632.8 nm laser radiation using the confocal Horiba- Jobin Yvon LabRam
micro-Raman spectrometer are shown in Figure 2.2. The observed Raman lines for the
crystalline and amorphous samples, which are largely in agreement with the Fourier-
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(a)

(b)

Figure 2.2 Raman spectra taken with the Horiba-Jobin Yvon LabRam micro-Raman
spectrometer using 632.8 nm laser excitation in: (a) The 100 to 3300 cm-1 range of asreceived, micronized crystalline griseofulvin (bottom), cryomilled griseofulvin sample
no. 2 (middle), and amorphous griseofulvin (top); and (b) The corresponding zoomed
spectra in the 1580 to 1740 cm-1 range.
transform Raman data of Feng et al [34], are listed and qualitatively assigned in Table
2.1.The lowest frequency lines at 152, 176 and 201 cm-1 in the crystalline phase are
assigned to mainly translational lattice modes of the griseofulvin molecule. The lattice
mode assignments have been made qualitatively in terms of a theoretical and
experimental study of similar modes in the Raman spectrum of the molecular crystal
sym-triazine [46], which showed that translational modes lie at higher frequencies than
the librational lattice modes. The calculations in ref [46] also indicate that the
translational eigenvectors in sym-triazine are mixed to some degree with those of the
librational modes, and this may also be the case in griseofulvin. The lines at 253 and 283
cm-1 are tentatively assigned to second order translation-libration and molecular
deformation-libration modes, respectively (see Table 2.1). Significant differences in
relative peak intensities and positions can be observed when the spectra of amorphous
and crystalline (or cryomilled) griseofulvin are compared. Most of these changes are
evident in the low-frequency region discussed above, as well as in the lines from 500 to
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1800 cm-1, and from 2800 to 3200 cm-1. The lines in the 560 and 640 cm-1 frequency
regions [Figure 2.2 (b)] observed for both crystalline and cryomilled samples, become
two broadened peaks in the amorphous sample with peaks at 565 cm-1 and 656 cm-1,
respectively, which are attributed to C-Cl stretching modes in the molecule [47]. It was
noticed that the formation of a strong line at 656 cm-1 strongly correlates with the
presence of a highly disordered or amorphous phase in the griseofulvin samples as
evident from the zoomed spectra shown in Figure 2.2 (b). It appears as a strong line in
amorphous griseofulvin (Figure 2.2 top) and in cryomilled sample 3 [Figure 2.3 (a)]
which is 63% amorphous as determined [34] from the DSC data shown in Figure 2.4. The
inset in the DSC scan in Figure 2.4 (b) shows a broad two step exothermic event for
cryomilled griseofulvin sample 3 starting at 60oC, which indicates crystallization of the
disordered component in the sample. The DSC scan of the as-received micronized
griseofulvin sample however shows high crystallinity with no indication of a
crystallization transition [Figure 2.4 (a)]. However, a glass transition-like step is seen
near 130oC for both the micronized and cryomilled samples.
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Table 2.1 Raman Frequencies and Qualitative Mode Assignments in Crystalline and
Amorphous Griseofulvin
Crystalline
Frequency (cm-1)
152
176
201
253
283
315
344

Intensity
m
m
m
w
m
m
w

Amorphous
Frequency (cm-1)
279
310
-

Intensity

Qualitative Assignment

broad,w
broad,w
-

Translational lattice mode
Translational lattice mode
Translational lattice mode
Translation+libration
Ring deformation + libration
Out-of-plane ring deformation
Out-of-plane ring deformation

359
384
435
555
570
592
635
658
828
974
1169
1185
1219
1245
1301
1353
1440

w
m
m
w
m
w
m
s
m
m
w
w
m
m
w
broad,m
w

385
439
560
594
656
978
1189
1228
1249
1307
1360
1445

broad,w
broad,w
broad,w
broad,w
s
m
broad,w
broad,w
broad,w
broad,w
sharp,s
broad,w

C-Cl deformation
C-Cl deformation
C-Cl deformation
Ring stretching
C-Cl stretching
C-Cl stretching
C-Cl stretching, ring deformation
C-Cl stretching
Cyclohexanone ring stretch
Benzene ring asymmetric stretch
CH-rocking
Ring vibration, -C-O-C stretch
-CH in-plane deformation
-CH in-plane deformation
-CH in-phase twist
-CH3 and -CH2 deformations
-Asym CH3 deformation

1454
1467
1592
1606
1624
1664
1712

w
m
w
w
s
m
s

1464
1476
1596
1621
1671
1715

broad,w
broad,w
broad,w
broad,s
broad,w
broad,s

-Asym CH3 deformation
-Asym CH3 deformation
C=O stretch
C=O stretch
C=O mixed with C=C stretch
C=C stretch in cyclohexanone
C=O stretch in benzofuran

2846
2883
2912
2932
2955
2978
3001
3018
3033
3052
3077
3107
3143

w
w
m
w
m
w
w
w
w
w
w
w
w

2855
2887
2913
2855
3032
3078
3108
3138

broad,w
broad,w
broad,w
broad,m
broad,w
broad,w
broad,w
broad,w

-CH symmetric stretch
-CH3 symmetrical stretch
-CH2 symmetrical stretch
-CH3 asymmetrical stretch
-CH2 asymmetrical stretch
-CH3 symmetrical stretch
-CH3 symmetrical stretch
-CH3 symmetrical stretch
Aromatic =CH stretch
-CH3 asymmetrical stretch
-CH3 asymmetrical stretch
-CH3 asymmetrical stretch
-CH3 asymmetrical stretch

s – small, m – medium, w – week
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Another feature in the Raman spectra is the disappearance of the 828 cm-1 line, attributed
to the cyclohexanone ring stretching vibration, with decrease in crystallinity of the
sample. The 1550 to 1800 cm-1 spectral range corresponding to the C=O stretching
vibrational frequencies of the benzofuran ring [30] displays a characteristic triplet of lines
which undergoes frequency shift, broadening, and decrease in relative peak intensity in
the amorphous phase. For crystalline and cryomilled samples, the first peak of the triplet
splits into three additional peaks at 1592, 1602, and 1624 cm-1 respectively [Figure 2.2
(b)], resulting probably from the interaction between the two C=O stretching modes and
partial conjugation in the neighboring cyclohexanone ring where the π-electron system is
delocalized [47, 48]. Conjugation in this part of the molecule is also significantly
distorted due to the presence of a 2-methoxy group in the cis-conformation relative to the
double bond on the cyclohexanone ring [49]. In the amorphous form, this splitting no
longer exists and only two broader peaks, both shifted to higher frequencies, are
observed.
(a)

(b)

(c)

Figure 2.3 Raman spectra recorded with 785 nm excitation using the Mesophotonics SE
1000 spectrometer in the 100 to 2400 cm-1 range of: (a) As-received micronized
griseofulvin sample (bottom) and cryomilled griseofulvin sample no. 3 (top), (b)
Cryomilled griseofulvin sample no. 2, and (c) Cryomilled griseofulvin sample no 1. The
boxed spectral region around 700 cm-1 on each panel are expanded and shown as insets
on the top right of each panel.
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Furthermore, examination of the C-H stretching region in the 2800 to 3150 cm-1 range
shows substantial loss in intensities over several peaks in the amorphous phase due to
changes in inter-molecular hydrogen bonding interactions.
(a)

(b)

Figure 2.4 Differential scanning calorimeter scans for: (a) As-received micronized
griseofulvin, and (b) Cryomilled griseofulvin sample 3. An expansion of the boxed-in
region between 60 and 110°C is shown in the inset.
2.4.3

Inelastic Raman Scattering Background

A key feature in the Raman spectra is a superimposed broad, excitation energyindependent inelastic scattering background observed both in cryomilled and amorphous
griseofulvin samples. This broad scattering was observed using two different Raman
spectrometers operating with 632 and 785 nm laser sources as shown in Figure 2.2 and
2.3, respectively. As discussed below, the observed background does not correspond to
fluoresence spectra taken from the same samples. This strong background in the Raman
spectra is assigned to lattice disorder induced by cryomilling [34, 36]. In addition to this,
particle size reduction to the range of the exciting laser wavelength will concomitantly
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give rise to Mie scattering in the milled samples [45]. In the largely amorphous samples
however the background scattering in the Raman spectra is primarily associated with
lattice disorder.
The inelastic scattering background for cryomilled griseofulvin was fitted to two
peaks using a Lorentzian function as shown in Figure 2.5 (a). The number of peaks
included in the fitting was determined by the lowest residual value obtained during
fitting. The two-peak fit suggests the existence of light scattering at two correlation
lengths – the narrower one associated probably with Mie scattering resonances discussed
earlier and the broader one to amorphous-like disorder in the sample. This is consistent
with the fact that only a single peak fit is obtained for the amorphous sample in Figure
2.5 (b).
(b)
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Figure 2.5 Fit of the inelastic Raman scattering background using a Lorentzian function.
Panel (a) shows the fit for cryomilled griseofulvin sample 2, and panel (b) shows the fit
for the amorphous griseofulvin sample.
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To obtain further insight into cryomilling-induced disorder and Mie scattering, the
effect on the Raman spectra of humidity and laser annealing of the cryomilled samples,
was studied as described and interpreted below:
(a) Effect of exposure to high humidity
Humidity treatment is known to result in crystal growth by Oswald ripening. Griseofulvin
is highly insoluble in water and exposure to water vapor in a humid atmosphere can
modify its surface properties similar to water acting as a plasticizer [50]. The humidity
treatment experiment conducted on cryomilled griseofulvin sample 1 showed a reduction
in background intensity as observed by a consistent decrease in the inelastic scattering
background compared with a minimal change in the as-received reference griseofulvin
sample [Figure 2.6 (a)]. The cryomilled sample showed a reduction in background
(a)

(b)

Figure 2.6 Comparison of the effect of annealing treatments on the Raman spectra of
cryomilled griseofulvin after: (a) Humidity exposure taken with the Mesophotonics SE
1000 Raman spectrometer and 785 nm excitation, and (b) 30 minutes of 632 nm laser
exposure taken with the Horiba-Jobin-Yvon Raman spectrometer. In each panel, the top
spectrum is that of cryomilled griseofulvin sample 1, the middle spectrum is that of same
cryomilled sample after annealing treatment (see text for details), and the bottom
spectrum is that of as-received, micronized griseofulvin from Sigma Aldrich.
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intensity at the location of the line at 656 cm-1 from the original baseline-corrected
intensity of 41,709 counts/seconds to a value of 30,038 counts/seconds. This represented
a 28% decrease in background intensity after seven days of exposure to high humidity.
The background intensity remained at approximately 30,750 counts/seconds after seven
days of exposure to high humidity, suggesting that most of the Oswald ripening occurred
near the initial exposure. The baseline corrected background intensity of the reference
sample remained essentially constant during this period. The observed decrease in Raman
background intensity is also consistent with the assignment of this signal to crystallite
size related disorder and Mie scattering rather than fluorescence.
(b) Effect of laser exposure
Laser annealing has been widely used to rapidly induce crystal nucleation in
amorphous silicon films [51-53]. In the case of organic materials, there are few reports of
successfully annealing crystal imperfections by inducing preferred molecular
arrangements [54-56]. In this study on cryomilled griseofulvin sample 1 using focused
632.8 nm laser irradiation, the most pronounced annealing occurred after only 30 minutes
of exposure as evident from Figure 2.6 (b). Background intensity was reduced for the
peak at 656 cm-1 from the original value of 28,000 to 13,000 counts/seconds. This is a
reduction of 54%, which can be attributed to annealing of defects and disorder due to
growth in crystallite size. The relative intensity of the Raman signal remained constant
with only minor deviation throughout the process indicating that no sample degradation
was occurring. As pointed out in the Introduction, laser annealing applies heat locally and
thus forms a solid-liquid interfacial strain region which is not formed in bulk thermal
annealing. Laser annealing would therefore rapidly remove defects or disorder, and by
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using rastering and broadening of the laser beam would have potential pharmaceutical
application as a processing procedure.
2.4.4

Fluorescence Spectroscopy

Defect states can exist in the band gap of insulating and semiconducting solids [57] which
give rise to fluorescence emission in molecular crystals with localized defects. As
discussed above, the Raman spectra from cryomilled griseofulvin is associated with
disorder and Mie scattering rather than localized defects. To further confirm this
interpretation, solid state fluorescence spectra of cryomilled griseofulvin were measured
and compared with the spectrum from as-received, micronized griseofulvin. The solvent
corrected UV-visible spectrum of a griseofulvin solution in acetone showed a strong
absorption band near 300 nm. This wavelength was therefore used to excite the
fluorescence emission spectra from both the as-received and cryomilled samples of
griseofulvin. The fluorescence spectra do show that as-received griseofulvin emits in the
mid-infrared range, but the emission is partially quenched by cryomilling. Moreover,
there is a lack of correspondence between the fluorescence and the background Raman
spectra. This is evident from the combined plots of the Raman and fluorescence
intensities versus wavelength shown in Figure 2.7.
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(a)

(b)

Figure 2.7 Raman (—) and fluorescence (---) spectral intensities plotted versus
wavelengths for cryomilled griseofulvin sample 1. Panel (a) shows the combined plot of
the Raman λex = 632 nm spectrum taken using the confocal Horiba Jobin Yvon LabRam
micro-Raman spectrometer and fluorescence spectrum taken with λex = 300 nm. Panel (b)
shows the combined plot of the Raman λex = 785 nm taken using the Mesophotonics
SE1000 Raman spectrometer and fluorescence spectrum taken with λex = 300 nm.

2.4.5

Powder X-Ray Diffraction (XRPD)

Wide-angle XRPD diffraction and scattering data obtained using CuKα radiation are
shown in Figure 2.8 (a) for the as-received micronized and cryomilled griseofulvin
sample 3, respectively. A broad scattering background is observed superimposed on the
diffraction peaks in the cryomilled sample, but except for an increase in scattering at
small angles, it is clearly absent in the as-received sample. The broad scattering in the
cryomilled sample can be deconvoluted into two Gaussian components as shown in
Figure 2.8 (b), pointing to the presence of disorder in the sample at two correlation
lengths. The XRPD data from a micronized sample has also been obtained using a
Synchroton X-ray source as a function of increasing temperature to the amorphous phase
through the melting point at 218oC, as shown in Figure 2.8 (c). As evident from the
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figure, a two-peak small-angle background is seen in the crystalline phase which persists
into the amorphous phase where the diffraction lines disappear.
(a)

(b)
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Figure 2.8 (a) Wide-angle X-ray powder diffraction patterns of cryomilled sample 3
(bottom) and as-received micronized griseofulvin (top) obtained using CuKα radiation,
λ =1.5406 Å; (b) Shows Gaussian function fits to the X-ray scattering background in the
wide-angle diffraction pattern of cryomilled griseofulvin sample 3 shown in panel (a);
and (c) Shows a sequence of plots of small-angle Synchrotron (1.09 Å) X-ray powder
diffraction patterns of as-received micronized griseofulvin as a function of temperature to
above the melting point at 218oC. The diffraction data in panels (a) and (b) have been
offset for easy viewing.
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2.5 Conclusions
A broad scattering background which can be deconvoluted into two components is
observed in the Raman spectra of cryomilled griseofulvin relative to the spectra of
reference samples of as-received, micronized griseofulvin. Comparison of the Raman
with fluorescence spectra has ruled out fluorescence from molecular defects and
impurities as the cause of the background scattering. It was concluded that structural
disorder and associated Mie scattering centers on nanosized crystals are produced on
cryomilling and contributes to the inelastic scattering background in the Raman spectra.
Similar but more intense background scattering, which can be fitted to a single
Lorentzian function, is seen in thermally produced amorphous griseofulvin. Wide-angle
XRPD data on cryomilled griseofulvin shows a diffuse scattering component which can
be fitted to two Gaussian functions due to disorder at two correlation lengths. Disorder at
longer lengths has been probed by small-angle XRPD using Synchrotron radiation on
micronized griseofulvin as a function of temperature from the crystalline to the
amorphous phase. Disorder at two levels, which persists without much change into the
amorphous phase, is also evident in this range.
Although it is widely known that Raman spectroscopy provides important
information regarding the presence of crystalline and amorphous forms based particularly
on the half-widths of Raman lines [15, 43], the results presented here show that additional
effects like the onset of diffuse scattering superimposed on the Raman lines in organic
solids can be used to assess the degree of disorder introduced as a result of mechanical
processing. This will therefore expand the application of Raman spectroscopy to the
characterization

and

quality

control

of

active

organic

pharmaceuticals.

CHAPTER 3
POLYMORPH CHARACTERIZATION AND STABILIZATION IN PROCESSED
AND UNPROCESSED ACETAMINOPHEN POWDERS

3.1 Objective
The objective of this chapter is to discuss and understand a novel approach developed
here to stabilize the metastable type II acetaminophen (APAP) polymorph. A new
interface of the stable type I APAP particles was created by micronization of the
crystallites or by dry-coating with nanosized silica. These micronized and coated particles
when converted to type II showed extensive long-term stability of the metastable type II
phase. Type II APAP is commercially important because it is known to have improved
tabletting properties. In previous studies, polymers have been used [58, 59] to formulate
a more stable type II APAP phase. The newly developed type II stabilization discussed
here can therefore have important implications in pharmaceutics.
Raman spectroscopy together with analysis by complementary techniques, such as
X-ray powder diffraction (XRPD), and conventional and intrinsic dissolution were used
to characterize the stabilized type II phase. The XRPD experiments also confirmed
Raman data showing that no structural change to type II occurs when type I was initially
micronized or dry-coated with nanosilica. Raman spectroscopy also showed the onset of
a time-dependent background scattering in stabilized type II APAP. This scattering is
similar to that seen in cryomilled griseofulvin [3] and is likely to be associated with the
further growth of small amounts of initially formed nanosized nuclei of the stable type I
polymorph detectable by XRPD, and defects associated with this growth process. It is
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expected that further optimization of the stabilization process would make the type II
phase indefinitely stable.
Topics that follow below are: Polymorphism in APAP, experimental methods
used, interpretation of the Raman spectra of APAP in its different phases, Raman spectral
monitoring as a function of time of the stabilized type II APAP, complementary
characterization of the type II phase by other techniques, and conclusions. In addition, an
oriented single crystal Raman study of type I APAP and a study of the spectra as a
function of temperature were performed. The latter is important in understanding thermal
changes that occur during milling processes employed to reduce particle size to improve
drug dissolution for pharmaceutical applications. The results and discussion of the single
crystal data are included in Appendix A at the end of this thesis. A corresponding
uniaxial pressure study simulating another component of the milling process is planned in
the future.

3.2 Polymorphism in Acetaminophen
Acetaminophen (APAP), one of the model drugs under investigation in this study is a
widely used analgesic drug and it is an excellent example of a polymorphic system as it is
known to exist in three forms with different crystalline packing, and a disordered,
amorphous form. Type I APAP is a monoclinic crystal, type II is orthorhombic, whereas
type III is too unstable for its structure to be determined. Type I (commercially available)
is the most stable at room temperature, but it has poor binding and densification
properties [60]. Both types I and II phases can be grown out of the molten state of APAP
crystals. The unstable type III can also be grown from the melt but only between two
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surfaces. From the commercial point of view, it is desirable to stabilize the metastable
type II due to its enhanced compression behavior and higher intrinsic dissolution rate [61,
62] compared to phase I. The compression properties of type I and II polymorphs relate
to different molecular packing in the two forms. The molecules form puckered layers in
the type I polymorph and flat sheets or layers in type II, as evident from Figures 3.1 (a)
and (b), respectively. Van der Waals intermolecular bonding occurs between the sheets
and stronger intermolecular hydrogen bonding exists among the molecules in the sheets.
As shown in Figure 3.2 (b), two types of hydrogen bonding, NH∙∙∙O and OH∙∙∙O, which
differ significantly in their corresponding bond lengths - 2.91 Å and 2.65Å in type I and
2.97Å and 2.72Å in type II phases, are observed in APAP crystals [42]. The shorter
(stronger) intra-layer hydrogen bonding in type I results in its higher melting point and
greater thermodynamic stability relative to the type II phase [63, 64]. Another interesting
feature is the higher plastic deformability of type II relative to the type I phase, which is
consistent with its flat layered architecture in contrast to the puckered architecture of the
molecules in the type I phase.
(a)

(b)

Figure 3.1 Unit cells of acetaminophen in: (a) Type I, and (b) Type II phases.
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(a)

(b)

NH

CH3
O

HO

Figure 3.2 (a) Molecular structure of acetaminophen, and (b) Type A and type B
hydrogen bonding between acetaminophen molecules in type I and type II acetaminophen
phases [42].
The relative orientation of layers of acetaminophen molecules in each structural
type relates to compaction properties and behavior of each phase under pressure. The
more planar orientation of the sheets in type II is attributed to its well-developed slip
system and higher plastic deformability [65]. Type I does not deform plastically since
the relative orientation of the molecular sheets resembles a zig-zag or puckered
arrangement. As a result, type I breaks by brittle fracture and requires binding agents
during manufacture to ensure that the tablets remain intact after compression.
Based on structural orientations, APAP can be classified as an unstable crystal
compared to the relatively stable griseofulvin which shows no polymorphic transitions
except for the amorphous state. It is of importance to understand how process design can
potentially benefit from polymorphic transitions of a crystal [66]. A large number of
publications have been devoted to APAP behavior during pharmaceutical processing [59-
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61, 67, 68] since its polymorphism is known to influence mechanical properties and
dissolution rate. In particular, the more elastic but metastable type II APAP can be
compressed directly but it transforms to the stable type I form within days. Several
techniques have been employed to stabilize type I APAP by using stabilization agents,
such a gelatin, polyvinylpyrrolidone (PVP) or starch [69]. Di Martino prepared the pure
orthorhombic type II phase of APAP for direct compression with fairly good results and
stability up to 11 months [67]. In the present study, two methods are used to increase the
stability of type II APAP. In the first method, metastable type II APAP is produced from
the melt using micronized type I APAP. In the second method, unmicronized type I
APAP is dry-coated with nano-silica and then type II APAP is generated from it.

3.3 Experimental Methods and Details
In this section the sources and preparation of the following APAP samples and
characterization methods used are described:
APAP I – Purchased form AnMar International Ltd (Bridgeport, CT), and used asreceived.
MAPAP (micronized APAP) I – Purchased form AnMar International Ltd (Bridgeport,
CT), and used as-received.
SiO2 APAP I – Hydrophilic Nano-silica was purchased from Cabot Corp (U.S.A). SEM
characterization showed the particle size of nano-silica to be about 40 nm. APAP I was
coated with 1% (w/w) nano-silica using the dry-coating technique described below.
Raman spectroscopy confirmed that no chemical and structural changes resulted from
nano-silica dry coating.
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Dry coating: The dry particle coating used the technique of magnetic assisted impaction
coating (MAIC), to disperse the nano-sized guest silica particles onto the surface of the
primary host particles. The dry particle method is discussed in detail in reference [70] and
was performed by Laila Jallo in Prof. Rajesh Dave’s group at NJIT.
APAP II – Normal type II APAP was generated from as-received crystalline type I
APAP. A few milligrams of APAP I was placed on a glass slide and melted at 190°C. To
obtain the type II phase, the hot melt was rapidly cooled in a freezer resulting in a thin
film of sample on the glass slide.
MAPAP (micronized APAP) II – Type II APAP was generated from MAPAP I
following the same procedure as for APAP II.
SiO2 APAP II – Type II APAP was generated from SiO2 APAP I following the same
procedure as for APAP II.
All samples prepared in this manner were stored in ambient conditions.
The formation of the orthorhombic phase II in all fabricated samples of acetaminophen,
in particular APAP II, MAPAP II, and SiO2 APAP II in thin films or crushed powders
(for dissolution studies) were confirmed by Raman spectroscopy.
Conventional Dissolution Rate (CDR): Dissolution analysis was performed using a
basket dissolution tester Distek 2100A USP apparatus 1 (North Brunswick, NJ). Samples
were tested according to the USP29-NF24 monogram for acetaminophen capsules. The
dissolution profile was obtained as per specified monogram conditions using a
dissolution tank with six dissolution vessels, 900 ml each, equipped with rotating baskets
with samples. Approximately 50 mg of sample was enclosed in a gelatin capsule as
shown in Figure 3.3 (a) and placed in each of the dissolution baskets, immersed into the
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vessel with DI water at 37oC, and rotated at a constant speed of 50 rpm. The water bath
temperature was constant during the experiment.
Aliquots of 5 ml were removed at time interval, t = 0, 5, 10, 15, 20, 25 and 30
minutes and analyzed using a UV-vis spectrophotometer (for instrument details see
Chapter 2). A calibration curve was generated by a set of freshly prepared standard
solutions of 0.005 mg/ml, 0.010 mg/ml, 0.025 mg/ml, 0.050 mg/ml, and 0.060 mg/ml
concentrations of as-received type I acetaminophen in water. All samples were run in
triplicate to create a dissolution profile and reliable data set. Dissolution analyses were
performed for the following types of acetaminophen: APAP I, APAPA II, MAPAP II,
and SiO2 APAP II.
Intrinsic Dissolution Rate (IDR): A Venkel, VK 7000 dissolution apparatus equipped
with compacted and rotating disk was employed, as shown in Figure 3.3 (b) to perform

(a)

(b)

Figure 3.3 (a) APAP capsule used for conventional dissolution analysis, and (b)
Schematic of an intrinsic dissolution apparatus consisting of a steel plunger and a die, and
a rotating shaft with attached sample holder immersed in the dissolution vessel [71].
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intrinsic dissolution on four batches of acetaminophen: APAP I, APAP II, MAPAP II,
and SiO2 APAP II. Sampling and experimental conditions were the same as described
above for the conventional dissolution rate study. A typical IDR apparatus consists of a
steel plunger and die, and a stainless steel sample holder for direct compaction as shown
in Figure 3.3 (b). Approximately 40 mg powder sample of APAP I was directly
compressed using a hydraulic press Carver Press, Model C, applying a pressure of 3 kN
for 30 seconds to form a 0.6 mm diameter disc inside the sample holder. The same
procedure was repeated for the remaining batches, where for each batch analysis was
performed in triplicate. The sample holder was attached to the rotating shaft and
immersed into the dissolution bath. Prior to analysis, the air pockets formed at the bottom
of the sample holder during immersion were carefully removed. Using a Cary 50 UV-vis
spectrometer, and a set of standards of the same concentrations as above, the mass of
dissolved acetaminophen was calculated after correcting for the change in volume and
including the disk area. The IDR analysis was performed in collaboration with Dr Shirlyn
Chen’s group at Boehringer-Ingelheim, Ridgefield, CT.
For both types of dissolution testing, thin films were gently crushed to generate
powders which were then confirmed to be type II APAP by Raman spectroscopy.
For brief descriptions of Raman spectroscopy, small and wide angle XRD, and SEM
instrumentation, see Chapter 2.
3.4 Raman Spectra of Acetaminophen Polymorphs
After X-ray diffraction, Raman scattering is one of the most widely used methods
employed to study polymorphism and structural transformations because of its high
sensitivity to crystalline structure. In the case of acetaminophen, three different
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arrangements of the molecules in the crystalline state are known besides the disordered
amorphous phase obtained from the melt. Among the three phases only type I is known to
be thermodynamically stable and is the form that is used in pharmaceutical applications.
However, it was discovered in this work that composite formation due to dry coating with
nanoscale silica and surface modification by top-down micronization provide long-term
stability to type II APAP possibly via the formation of a new interface which stabilizes
the molecular architecture of this normally metastable phase. As previously discussed in
Chapters 1 and 2, Raman spectroscopy is particularly suited to understand evolving
structural behavior and is therefore used here as the primary tool to monitor the changes
in type II APAP as a function of elapsed time. Raman spectra shown in Figure 3.4,
together with the frequencies and their possible assignments in Table 3.1, for all four
types of APAP have been measured down to 100 cm-1 and are in essential agreement with
the data previously reported by both Szelagiewicz et al [72] and Kauffman et al [73].
Raman lines below 200 cm-1, studied for the first time to the best of our knowledge, are
assigned to inter-molecular or lattice modes which are particularly sensitive to the
crystalline arrangements and clearly show differences between the four types of APAP
phases. For type I, the lowest frequency lines at 136 cm-1 and 155 cm-1 are assigned to
largely translational motions of the acetaminophen molecule, similar to observations in
griseofulvin discussed in Chapter 2. Both of these lines shift to lower frequencies (127
cm-1 and 145 cm-1, respectively) in type II APAP. In the amorphous phase, long-range
crystalline order is lost and the molecules are randomly oriented. The low frequency
Raman lines persist in the amorphous phase due to some short-range order but are
substantially broadened due to long-range disorder. The low frequency Raman spectrum
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of type III APAP is interesting. The translational mode features are not evident and
appear to be embedded in a broad scattering background similar to that seen in
cryomilled griseofulvin (see Chapter 2). The observation of a strong scattering
background suggests that the type III structure is highly defected and probably stabilized
by these defects.
Raman lines attributed to intra-molecular vibrational modes are observed at
frequencies above 200 cm-1 for the different polymorphs and the amorphous phase as
shown in Figure 3.4 (a). Changes in these lines occur in the different phases due to
changes in local potentials and are more subtle than those for the Raman features
assigned to inter-molecular or lattice vibrations discussed above. More detailed views of
the Raman features in the spectral regions between 1200 to 1280 cm-1 and between 1500
to 1650 cm-1 are indicated in Figures 3.4 (b) and (c), respectively. The Raman lines in the
1200 to 1260 cm-1 frequency region correspond to C-N, C-H, and phenyl ring vibrations
[47]. The characteristic C-N stretching Raman line at 1237 cm-1 for type I APAP
develops into two well resolved peaks at 1221 cm-1 and 1245 cm-1 in type II APAP due to
change in local symmetry. Further, there is substantial broadening of the 1237 cm-1 line
in the amorphous phase with almost no frequency shift relative to that of the line in the
type I phase. In the type III phase this line broadens and upshifts by 6 cm-1 to 1243 cm-1
indicating some strengthening of the C-N bond.
Additionally, other changes in the intra-molecular vibrational lines are observed
in the Raman spectra as a function of crystalline polymorph or amorphous phase in the
1500 to 1650 cm-1 frequency region shown in Figure 3.4 (c). Here, changes occur in the
relative intensities and peak positions of Raman lines that are attributed to –N-H
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deformation and C=O stretching modes. The strongest lines for type I APAP are seen at
1611 cm-1 and 1649 cm-1 and are assigned to –N-H deformation and C=O stretching
modes, respectively. In the amorphous phase both of these lines upshift by 9 cm-1
together with significant broadening as well as increase and decrease in relative peak
intensity, respectively. These changes are most likely associated with the absence of
ordered intermolecular interaction in the amorphous phase and type A and B hydrogen
bonding explained above. The upshift in the peak positions indicate that the force
constants for N-H deformation and C=O stretching increase probably because intermolecular interactions are disrupted in the amorphous phase. In case of type III APAP
intermolecular interactions persist, and the line at 1611 cm-1 upshifts by 3 cm-1 whereas
the line at 1649 cm-1 downshifts by 2 cm-1 due to changes in the local inter-molecular
potentials. For type II, the type I APAP line at1611 cm-1 splits into two peaks at 1578
cm-1 and 1623 cm-1 indicating substantial changes in the hydrogen bonding interactions.

55
(a)
14 000
13 000
12 000
11 000

Amorphous

10 000
9 000

Scattering background due to defects/disorder

7 000

Type III, Highly Unstable

6 000
5 000

Type II, Orthorhombic, Metastable

4 000
3 000
2 000
1 000

Type I, Monoclinic, Stable

0
500

1 000

1 500
Raman Shift (cm-1 )

(b)

2 000

2 500

3 000

(c)

APAP all types on top-typeI to bottom-amorphous.esp

APAP all types on top-typeI to bottom-amorphous.esp

16000

16000

14000

14000

12000

12000

10000

10000
Arbitrary

Arbitrary

Intensity

8 000

8000

8000

6000

6000

4000

4000

2000

2000

0

1200

1205

1210

1215

1220

1225 1230 1235 1240
Raman Shift (cm-1)

1245

1250

1255

1260

1265

1540

1560

1580

1600

1620
1640
Raman Shift (cm-1)

1660

1680

1700

Figure 3.4 Raman spectra of acetaminophen polymorphs and its amorphous phase
prepared directly from its stable type I phase in the spectral regions: (a) 100 to 3500 cm-1,
(b) 1200 to 1260 cm-1, and (c) 1500 to 1650 cm-1. Color coding: Green (amorphous), blue
(type I), red (type II) and black (type III).
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Table 3.1 Raman Frequencies and Qualitative Mode Assignments of Acetaminophen in
its Three Polymorphic and Amorphous Phases
Type I
(cm-1)

Type II
(cm-1)

Type III
(cm-1)

135
155
205
218

127
145
172
208
-

146
183
210
-

143
215

326
388
462
501
649
796
839
856
1169
1237
1278

330
388
452
5050
649
796
856
1169
1221
1245
1278

330
388
457
505
646
799
862
1172
1242
1278

330
388
458
508
650
800
831
864
1174
1238
1280

1324
1371
1559
1611
1649

1326
1376
1578
1609
1623
1649

1321
1374
1562
1614
1647

1328
1378
1562
1620
1658

2937
3016
3058
3072
3083
3110
3163
3326

2940
3018
3069
3083
3111
3166
3328

2928
3009
3045
3067
3095
3095
3159
3329

2938
3018
3072
3107
3155
-

Amorphous Qualitative Assignments
(cm-1)

Translational lattice modes

Out-of-plane ring deformation
Out-of-plane ring deformation
Out-of-plane ring deformation
In-plane ring deformation
Phenyl ring stretch [74]
C-H out-of-plane bend
Phenyl ring C-H stretching
C-H in-plane bend
C-C stretch carbon phenyl ring
C-N stretch
O-H and C-O combination, (ar) C-N
stretch
C-H bend
-CH3 umbrella mode
-H-N-C=O stretch [74]
-N-H deformation [74]
C=O stretch [74]
-CH3 symmetric stretch
-CH3 symmetric stretch
-CH3 symmetric stretch
-CH3 symmetric stretch
-CH3 asymmetric stretch
-CH3 asymmetric stretch
-CH asymmetric stretch, phenyl ring
-CH asymmetric stretch, phenyl ring
O-H stretch
N-H stretch
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3.5 Monitoring the Stability of the APAP II Polymorph by Raman Spectroscopy
As noted above, new interfaces in type I APAP were created by micronizing and dry
coating with nanosized silica to form a stabilized type II APAP. In this section results on
monitoring the stabilized phase by Raman spectroscopy as a function of time are
discussed.
The spectra over a period of months for type II APAP prepared from micronized
and dry-coated type I APAP are displayed in Figure 3.5 (a) and (b) show that the Raman
spectral features of type II APAP discussed above remain unchanged. No molecular scale
events appear to take place based on the frequencies, intensities and linewidths of the
Raman lines. However, a broad scattering background superimposed on the Raman
spectra similar to that seen in griseofulvin [3] is observed. The intensity of this scattering
increases up to 180 days for the sample from micronized APAP and then starts to
decrease as shown in the inset in Figure 3.5 (a). The scattering intensity for the sample
from dry-coated APAP shown as an inset in Figure 3.5 (b) appears to saturate already
after 90 days, but has been monitored so far for only 150 days.
One interpretation of the background scattering is that it is associated with
scattering from defects associated with growing nanocrystallites of the stable type I phase
in the matrix of the type II phase, albeit initially form in quantities that are too small to be
observed in the Raman spectra but detectable by XRPD as discussed below. With time
these defects anneal out as indicated by reduction or saturation in the background
scattering intensity. Further studies will continue in the type II sample from nanocoated
APAP to see if a reduction in background scattering intensity occurs there as well.
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Although a quantitative model needs to be developed, it can be conjectured that
the stabilization of the type II phase by dry coating and micronization occurs through
local potential energy minima of the conformational space at the interface between APAP
and nanosilica, and between surface and bulk APAP, respectively. As an interesting
observation, it was noticed throughout multiple sample preparations that the formation of
the metastable type II APAP phase appears to begin at the sample surface. In dry coated
and micronized APAP, stabilization can occur via immobilization of the type II structure
at the coating-APAP and surface-bulk interface followed by rapid crystallization of this
phase throughout the film formed from the melt. Further improvement in phase II
stabilization is therefore possible via APAP improved dry coating and APAP particle size
reduction.
(a)

(b)

Figure 3.5 Raman spectra showing the stabilization of type II acetaminophen as a
function of time for samples prepared by melt formation from: (a) Micronized type I
APAP I, and (b) Nano-silica dry-coated type I APAP.
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3.6 Characterization of the APAP II Polymorph by SEM, XRPD and Dissolution
Measurements
3.6.1

Scanning Electron Microscopy (SEM)

The SEM studies were carried out to image the physical features of the samples since
various sample types with different morphologies were employed: as-received powders,
fabricated thin films, and powders from crushed films. The orthorhombic and monoclinic
phase II and phase I polymorphs can be easily recognized due to differences in their
corresponding crystal habit, especially when a high magnification tool, such as SEM is
used. Figure 3.6 (a), (b), and (c) show representative images of as-received crystalline
APAP I, as-received micronized APAP I, and nano-silica coated APAP I, respectively.
Figures 3.7, 3.8, and 3.9 show SEM images of APAP II, MAPAP II, and SiO2 APAP II,
fabricated as thin films. Interestingly, APAP II in Figure 3.7 showed a large number of
air pockets formed during film solidification which explains the fact that substantial
absorption of water vapor through the air pockets accelerates the transition to the stable
APAP type I. Air pockets were not observed for MAPAPA II and SiO2 APAP II samples.
Crystal habits of both type I APAP (monoclinic) and type II APAP (orthorhombic) were
observed on the surface of nanocoated SiO2 APAP II films shown in Figure 3.9 (indicated
by arrows) consistent with XRPD results discussed below.
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(a)

(b)

(c)

Figure 3.6 SEM images of (a) As-received crystalline APAP I, (b) As-received
micronized APAP I, and (c) Nano-silica dry coated APAP I.

Figure 3.7 SEM images of APAP II sample fabricated as a thin film. Formed air pockets
are indicated by arrows. Images are shown in order of increasing magnification.
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Figure 3.8 SEM images of MAPAP II sample fabricated as a thin film. Images are shown
in order of increasing magnification.

Type II
Type I

Figure 3.9 SEM images of SiO2 APAP II sample fabricated as a thin film. Presence of
monoclinic and orthorhombic crystals indicated by arrows.
3.6.2

X-Ray Powder Diffraction (XRPD)

Wide-angle XRPD diffraction and scattering data obtained using CuKα radiation are
shown in Figure 3.10 (a) for as-received MAPAP I and MAPAP II and Figure 3.10 (b)
for dry-coated SiO2-APAP type I and fabricated SiO2-APAP type II samples,
respectively. XRPD data for MAPAP I and II, and SiO2-APAP I, agree with that
published by Welton et al [75]. By contrast, the XRPD pattern for type II SiO2-APAP is
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different from that reported in the literature. After careful evaluation of the diffraction
patterns and SEM images it was concluded that the XRPD pattern resulted from the
presence of small quantities of type I (not detected by Raman) in the primarily type II
phase sample, consistent with the SEM images discussed in section 3.6.1 above.
(a)

(b)

MAPAP II

SiO2 APAP I I

MAPAP I

SiO2 APAP I

Figure 3.10 Wide-angle X-ray powder diffraction patterns of acetaminophen samples
obtained using CuKα radiation, λ =1.5406 Å, (a) MAPAP I and MAPAP II and (b) SiO2
APAP I and SiO2 APAP II.
3.6.3

Dissolution Profiles

By definition, “dissolution is defined as the process by which solid substances enters a
solvent to yield a solution” [71]. Conventional dissolution rate (CDR) analysis was
carried out to test the behavior of the stabilized type II APAP samples. Since all samples
used for CDR were enclosed in gelatin capsules, the initial physical state of the sample,
such as micronized size or surface coating with nano-silica, were not accounted for.
Figure 3.11 (a) compares the dissolution profiles of types I and II APAP with stabilized
type II APAP samples via conventional dissolution rate analysis. It can be seen that
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almost complete mass release is seen in type I APAP within the first 10 minutes of
analysis; this was followed by type II APAP. The two modified acetaminophen type II
samples showed no improvement in dissolution rate, in fact it took almost three times as
long, compared to APAP type I, for these samples to completely dissolve.
Since modified APAP type II samples are generated from micronized and silicananocoated APAP I, potential variations in the surface area are created which affect the
conventional dissolution rate. Intrinsic dissolution rate (IDR) is characteristic of the
initial physical state of the sample. IDR is described by the equation 3.1 which is also
referred to as the Noyes-Withney equation [76]:

J

dm 1
  k Cs  C 
dt A

(3.1)

where,
dm/dt – Rate of increase of the mass of solute released per unit time t
k – Mass transfer coefficient
A – Surface area of the sample
Cs – Intrinsic solubility at sample surface
C – Concentration of solute dissolved at time t.
Equation 3.1 can be further reduced to equation 3.2 since for sink conditions Cs >>C,

J 

dm 1
  k Cs 
dt A

(3.2)
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Equation 3.2 indicates that the rate of dissolution may vary if the surface area of
the solid is altered. There are many known surface modification techniques, such as
particle size (micronization), crystalline form of a solid (polymorphs), or coating that can
act as a barrier to the dissolution rate. Since both micronization and surface coating were
employed here to generate type II APAP samples, intrinsic dissolution with a compressed
disk of known area was employed to eliminate surface area and surface electrical charges
as dissolution variables. The dissolution rate so determined can be correlated with the
physical properties of the sample [76].
(a)

(b)

Figure 3.11 Dissolution profiles for acetaminophen samples based on (a) Conventional
dissolution rate, and (b) Intrinsic dissolution rate (IDR).
Figure 3.11 (b) shows the linear IDR profile of a compressed disk under sink
conditions. Both modified type II APAP (MAPAP II and SiO2 APAP II) show increase in
dissolution profile compared to results from conventional dissolution. Improved IDR for
MAPAP II indicates that micronization not only promotes sample stabilization but also
modifies the surface area resulting in the highest dissolution rate. From the dissolution
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profile of the stable type I APAP phase, it can be concluded that it dissolves the slowest,
whereas the corresponding metastable type II APAP has improved release profiles. Dry
coated type II APAP also showed improvement in mass release, but the improvement
relative to type I APAP is small.

3.7 Conclusions
New interfaces in type I APAP were created by micronization or by dry-coating with
nanosized silica. Raman spectroscopy was utilized, among other analytical (XRPD and
SEM) and dissolution techniques to, respectively, monitor the stability and determine the
dissolution profile of the newly developed type II APAP phase. Raman studies conducted
on the stabilized metastable type II phase as a function of time showed stability for over
18 months; however, a diffuse scattering background superimposed on the Raman
spectra, observed previously in griseofulvin, developed with time and was attributed to
the growth of nanosized nuclei of the stable type I polymorph in the type II phase matrix
of the particles. No molecular changes at the new interfaces were, however, detected
based on the Raman spectra taken as a function of time. In addition, improved dissolution
profiles for the stabilized type II APAP relative to the type I phase were observed. The
results obtained therefore indicate the potential of the stabilized type II APAP phase for
use in pharmaceutical applications.

CHAPTER 4
IN-LINE AND OFF-LINE RAMAN SENSING OF PHARMACEUTICAL
DOSAGE FORMS

1.4 Raman Spectroscopy as a Sensing Tool
Raman spectroscopy is a significant analytical tool for process understanding in the
pharmaceutical industry. Process and bench top applications exist for Raman
spectroscopy and can be applied for qualitative and quantitative process evaluation.
Successful pharmaceutical applications include blend uniformity, reaction monitoring,
solid quantification, coating monitoring and probably most significantly, crystallization
monitoring and polymorph detection and analysis [3]. Significant technological
development in the area of instrumentation has allowed the implementation of fiber
optics, immersion and big spot size probes, and dispersive components into Raman
systems, making them highly robust and versatile tools for on-line, in-line, and off-line
characterization in the pharmaceutical industry [4].
Spectral imaging using Raman spectroscopy is a common tool for chemical
characterization of various pharmaceutical dosage forms [8, 24, 77] including the newly
developed thin polymeric films in Test Bed 2 of the NSF-Engineering Research Center
[24]. Since the film’s design employs small API particles, for example that of
griseofulvin uniformly dispersed in a film composition, it is an excellent micro- and
nano-particle based system for alternative delivery. Performance and drug behavior is
based on the film’s advanced functionality and ability of the active media to maintain
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small particles ranging between 10 µm to 300 nm in a non-agglomerated form. This
makes it possible to precisely control the release of the drug.
Low dissolution rates of poorly soluble drugs [27, 78, 79] and content uniformity
of drugs administered in low doses [80-82] are the most common issues encountered by
the pharmaceutical industry. In films, the small particle size in a uniformly dispersed
configuration can significantly affect some of the commonly encountered problems by
potentially enhancing the dissolution rate of poorly soluble drugs, in particular
griseofulvin, and the content uniformity of drugs administered in low doses.
Since the crystalline state of any API affects its use in pharmaceutical applications
as a drug processed into pills or capsules for pharmaceutical applications, it is necessary
to develop effective, fast, and non-destructive methods that would allow elimination of
crystalline defects and potential polymorph formation [6-8]. Implementing Raman and
NIR spectroscopic techniques as on-line and in-line sensing tools, provides molecular
level understanding and monitoring of solid-state behavior, uniformity, and particle size
distribution in a dosage form.
In this Chapter, Raman imaging provides the spatial distribution of micro- and
nano-sized griseofulvin in the polymeric films and explores the possibility for developing
innovative dissolution methods based on drug allocation on the film’s surface [24].
Various film compositions were prepared and analyzed by Raman imaging [39]. In
addition, complementary Raman and NIR imaging (by Jarez, Zarow et al [24]) was
performed on a set of four films and will be discussed below.
Raman spectroscopy is also used to demonstrate the feasibility of in-line Raman
spectroscopy to dynamically monitor the crystallinity and particle size of griseofulvin in
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stable nanosuspensions that are being developed (Bhakay, to be published). The behavior
of griseofulvin nanosuspensions will be presented and discussed in sections below.

4.2 Chemical Mapping and Imaging
Applications of vibrational spectroscopy, Raman and NIR in particular, have gained
significant recognition in the pharmaceutical community as techniques for analyzing
solid dosage formulations [72, 83-86]. The concept of chemical imaging is relatively
new as it was developed and applied to pharmaceutical samples in the mid-1990s [87]. It
was quickly realized that this techniques can offer much needed understanding and detail
information to solve problems related to product development. Both Raman and NIR
chemical imaging (CI) provide chemical and physical information at different scales of
scrutiny [24]. The presence of specific spectral bands can be used to identify components
of the formulation, their spatial distribution, particle sizes, and most importantly their
crystallinity and polymorphic states. The main advantage of using vibrational techniques
is characterization of dosage forms on an as-received basis with no sample preparation.
NIR and Raman spectroscopy, given their complementary origins, result in characteristic
vibrational spectral features. NIR spectra show broad second-order bands due to
combinations and overtones of fundamental vibrations which sometimes are difficult to
assign to the individual functional groups [88]. On the contrary, Raman-active vibrations
above 200 cm-1 are associated with narrower first-order spectral lines resulting from
interatomic bond vibrations [6]. In the solid-state, the line-shapes and line-widths, and
splittings of these narrow bands can also provide important information on the
crystallinity of the investigated material [23].
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Among the advantages of using Raman CI for characterization of formulations
during pharmaceutical development and manufacturing processes are: chemical
visualization of spatially resolved components of a sample mixture at a microscopic
scale, visualization of impurities and degradants generated during processing,
determination and quantification of different physical forms, and low limits of detection
per mapped area (better than 0.025 %) [8, 89, 90]. The main disadvantage of Raman CI is
the long acquisition time necessary compared to NIR-CI, and if the mapped area is
relatively small, a large number of maps are required to be representative of the bulk
sample.
Principle of Raman Imaging: Raman CI can be acquired using point and line mapping,
or global illumination. Independent of the mapping technique used, the collected data
result in generation of the same chemical image, also called hyperspectral data cube [91]
presented in Figure 4.1 (a). This 3D block contains two types of data: spatial, composed
of x and y coordinates and spectral, composed of wavelength and intensity. Due to the
detector design, the 3D cube results, however, in a 2D representation.
During point mapping, the sample area is selected first using the microscope to
focus on the specific detail or location on the surface. The area is then divided into
mapping points and the hyperspectral data cube is generated by acquiring the entire
Raman spectrum (or specific range) at each point for all points as shown in Figure 4.1
(b). The line mapping is obtained in similar fashion, except the laser source is stretched
into a line and results in timely completion of the map [92] comparing to point mapping
[Figure 4.1 (c)]. When a global illumination technique is used, the selected sample area is
exposed to defocused laser radiation allowing coverage of a much larger area as shown in
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Figure 4.1 (d). The sample response is obtained at a specific wavelength simultaneously
for the entire illuminated area. Since point and line techniques collect high quality Raman
spectra, and are not wavelength specific, they generate a wealth of chemical information
from the mapped sample area. Global illumination, on the other hand, is a much faster
technique but may result in poor chemical information since the emphasis is on the
spatial information.
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(b)

(c)

(d)

Figure 4.1 Schematic representations of hyperspectral cube and approaches to chemical
imaging: (a) Methods of acquiring the hyperspectral cube; (b) Point mapping; (c) Line
mapping; and (d) Illumination.
To visually represent a hyperspectral data cube as a chemical image, various
statistical tools need to be implemented. It should be remembered that a hyperspectral
data cube represents a set of raw data and can become a chemical image that shows
intensity variation of these raw data only upon statistical processing. The data processing
tools used in this study are described in section 4.3.

4.3 Analysis of the Hyperspectral Data Cube
During acquisition of a spectral image, a very large amount of data is collected. For
example, a Raman hyperspectral data cube with spatial dimensions of 20 µm x 20 µm and
120 x 120 pixels can result in 14400 spectra, each with approximately 3000 data points.
To extract the relevant chemical, physical and spatial information from such a dense
dataset, various statistical algorithms need to be employed. This practice has led to the
development of a new chemical field that is also known as chemometrics [6]. The
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majority of commonly used chemometrics techniques rely on univariate and multivariate
classification of the data. For a univariate approach, only a specific wavenumber of each
component is selected to create a chemical image, whereas multivariate analyses take into
account all spectral information contained in the data cube and employ techniques like
Principal Component Analysis (PCA) [93], Partial Least Squares (PLS) [94], or Direct
Classical Least Square (DCLS) to produce a chemical image.
Typical steps in a data analysis procedure consist of unfolding a threedimensional

data

cube

into

a

two-dimensional

representation,

preprocessing,

classification of data, and image processing [77]. Data preprocessing is usually
performed to remove the non-chemical biases that arise form scattering effects due to
surface roughness, particle size, random noise, or optical effects. These techniques
include mathematical methods such as:


Standard Normal Variate (SNV) – identical to auto-scaling, reduces slope
variation from spectrum to spectrum. It results in a similar background in all
spectra and therefore enhances the differences due to band intensities



Smoothing – improved S/N ratio by averaging signal over many spectra using
Fast Fourier transform (FFT) or Savitsky-Golay methods



Mean-centering – subtracting the mean from all spectral data resulting in the
shift of the data towards the mean



Normalization – results in similar scale of the intensity range for all spectra.



Baseline Flattening – polynomial functions are used to fit a baseline followed
by its subtraction from the spectral baseline



Derivatives – 1st and 2nd are most commonly used. They eliminate slopes or
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curved background in spectra due to fluorescence, structural defects, or
Rayleigh wings and resolve peak overlaps [6].
After data preprocessing, qualitative and/or quantitative analysis is performed.
Among the most recognized processing methods are PCA, PLS, and DCLS, which are
explained briefly below.
In case of PCA, a set of orthogonal representations is found for the analyzed data
cube by expressing the data matrix (M) as the product of two other matrices – the scores
matrix T and the transpose of the loadings matrix L as in the following equation 4.1:

X = TLT

(4.1)

PCA gives information on the most variance in the observed variables and is used as a
prediction or criterion of a variable in subsequent analyses [91]. While PCA calculates
loadings independently of the concentrations of the components, in PLS spectra are
highly correlated to the concentrations resulting in loadings that account for the
maximum variance in both the spectra and the concentrations [6]. PLS classification can
be also calculated using pure reference spectra to extract the distribution map. This
technique is called PLS discriminant analysis (PLS-DA). Another chemometrics
technique is DLCS, also known as Ordinary Least-Square algorithm (OLS). DLCS finds
linear combination of data from pure components and creates a combination that most
closely matches the original data providing quantitative estimates of the concentrations
[95].
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In the research presented, polymeric films 1-3 and 5 were analyzed by PLS-DA
and the results are explained in the following section. All of the remaining films were
analyzed using a DCLS algorithm. Particle size calibration was performed using the
univariate method.

4.4 Experimental Details
Griseofulvin, a poorly soluble drug, was used as a model active pharmaceutical
ingredient (API) in micronized and nanosized forms. The total of nine films was
investigated in this study to determine the distribution of the embedded griseofulvin in
the polymeric matrix. Hydroxypropyl methylcellulose (HPMC) was selected as the filmforming excipient for all films. In some cases, sodium dodecyl sulfate (SDS) and glycerol
(GLY) were added as surfactant to the HPMC matrix, as indicated in Table 4.1.
Micronized griseofulvin and HPMC were purchased form Sigma-Aldrich Corporation
(Milwaukee, WI), SDS was purchased from Fisher Scientific (Fair Lawn, NJ), and GLY
was supplied by J. T. Baker Inc (Phillipsburg, NJ). Films labelled as 6, 7, 8 and 9 were
prepared from griseofulvin nano-suspensions with particle size of approximately 260 nm.
Films labelled as 12C, 1, 2, 3, and 5 were prepared form micronized griseofulvin with a
particle size of 10 µm.
4.4.1

Preparation of Griseofulvin Films and Nanosupensions

Films 1, 2, 3, and 5: Blends of micronized API and HPMC were prepared by first
dispersing the two components together in hot water (80oC), followed by stirring for 12
hours and drying at room temperature. The films produced have a thickness on the order
of 100 µm. A total of five film batches were prepared but only four films were selected
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for this study as indicated in Table 4.1 and analyzed by Raman mapping and NIR-CI.
Since only films with different drug concentrations were considered, film 4 was not
studied because it had the same concentration as film 2. Every sample was analyzed by
the two imaging methods, Raman and NIR spectroscopy. However, the instrumental
setup precludes the possibility of analyzing the exact same region of the film by the two
methods.
Films 12C: Prepared as films 1, 2, 3, and 5 above with addition of different SDS and
GLY amounts during the dispersion of the blends as indicated in Table 4.1.
Films 6, 7, 8, and 9: Blends were prepared in the same fashion as for film 12C and
milled using a MicroCer media mill from Netzsch Fine Particle Technology (Exton, PA)
with 400 µm zirconia beads and milling speed of 3200 rpm to generate sub-micron
particles. Upon media milling completion, t = 64 minutes, stable griseofulvin
nanosuspensions were obtained and used to cast films dried at various temperature
conditions as indicated in Table 4.1. Particle size analysis at t = 64 minutes was
performed with Beckman Coulter LS13320 laser diffraction particle size analyzer from
Beckman Coulter (Brea, CA) , and determined to be in a range of 240 nm (D90).
Griseofulvin Nanosuspension: For in-line particle size characterization and crystallinity
study of griseofulvin nanosuspension, new blends were produced with the following
concentration: 8.84% (w/w) griseofulvin, 2.21% (w/w) HPMC, and 0.44% (w/w) SDS;
and media milled using same technique as in case of films 6 through 9. During media
milling, periodical sampling of the suspension was performed at t = 1, 2, 4, ….64
minutes. Laser diffraction spectrometry was used to analyze the particle size of the
collected samples. Results of particle size analyses are presented in Table 4.2. Solid-state
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analysis of griseofulvin nanosuspensions was performed by collection of static and
dynamic (suspension was magnetically stirred) Raman spectra recorded with a fiber optic
Raman spectrometer.

Table 4.1 Prepared Compositions of Griseofulvin Films
Drying
Temperature (°C)

Film Name

Griseofulvin
(%)

HPMC
(%)

SDS
(%)

GLY
(%)

1

57.00

43.00

-

-

25.00

2

50.00

50.00

-

-

25.00

3

44.00

56.00

-

-

25.00

5

36.40

63.60

-

-

25.00

12C

9.30

69.70

0.02

20.90

25.00

6

49.14

29.66

2.00

18.76

25.00

7

37.63

51.97

1.87

8.51

25.00

8

37.63

51.97

1.87

8.51

50.00

9

37.63

51.97

1.87

8.51

42.00
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Table 4.2 Particle Sizes of Sampled Griesofulvin Nanosuspensions
Milling Time (min)

4.4.2

Particle Size [D90 (µm)]

Particle Size [Mean (µm)]

0.00

7.29

3.96

1.00

6.16

3.18

2.00

5.71

2.86

4.00

4.71

2.07

8.00

1.63

0.92

16.00

0.73

0.48

32.00

0.48

0.26

48.00

0.31

0.19

64.00

0.24

0.16

NIR Chemical Imaging

The near infrared hyperspectral images were obtained by Jerez at the University of Puerto
Rico, Mayaguez and acquired using a SyNIRgi (Spectral Dimensions Inc., Olney, MD)
instrument. The images were obtained in the diffuse reflectance mode with a spatial
resolution of 320 X 256 pixels. A 10 μm per pixel objective was used to analyze a film
area of approximately 3.2 x 2.6 mm. The spectra were obtained with 5 scans in a spectral
range of 1200-2400 nm. Two different areas within the same gel strip film were analyzed.
4.4.3

Raman Chemical Imaging

Films 1 - 3, 5 and 6 - 9: Raman mapping spectra were collected using a Jobin
Yvon/Horiba LabRAM micro-Raman spectrometer, with 632.81 nm He/Ne laser
excitation and a 10x objective. For higher magnification objectives, such as 50x and
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100x, significant de-focusing was observed on the sample surface due to heating, which
precluded mapping experiments. The Raman spectra were recorded in the 800-1650 cm-1
range. The films were analyzed “as is,” without sample preparation or modification, and
no sample damage was observed during the experiment.

The data collected were

analyzed using the Malvern NIR Instrument’s Isys software to generate chemical images.
For films 1 - 3 and 5 a typical chemical map consisted of 30 x 30 pixels, with a
step size of 0.3 μm. The mapping was performed by acquiring Raman spectra from thirty
points in the x direction and 10 µm distance and repeating the same for 10 µm in the y
direction. Since the laser was moved by 0.3 µm each time, a new Raman spectrum was
acquired, which resulted in high sampling frequency along both directions giving higher
spectral content and therefore more accurate information on chemical behavior and
borders of particle domains. This relatively high sampling frequency at the laser spot size
results in sampling of 10% of new area at each step size, giving more thorough chemical
evaluation of the film components. Each spectrum was acquired for 3 seconds at each
pixel or stage position resulting in a total acquisition time of 1 hour and map size of
approximately 10 μm x 10 μm. Achievable laser spot size and spatial resolution of the
micro-Raman spectrometer were calculated to be 3 µm and 1.5 µm respectively and were
calculated based on lateral spot size (1.22λ/numerical aperture), and spatial resolution =
0.61λ/numerical aperture) [96]. Four maps were recorded for films 1-3 and 5. Films 3 and
5 were subsequently re-analyzed resulting in an additional five maps for films 3 and 5.
Chemical maps for films 6 - 9 consisted of 30 x 30 pixels with step size of 1 µm.
Raman spectra were acquired from thirty points in the x direction and 30 µm distance and
repeating the same for 30 µm in the y direction resulting in the 30 µm x 30 µm mapped
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area. Single Raman spectrum acquisition time and total mapping acquisition time were as
above.
For film 12C, chemical maps were performed with a Jobin Yvon/Horiba
LabRAM Aramis confocal Raman microscope using 632.8 nm He/Ne laser excitation
and a 100x objective with a spatial resolution of 1 µm. Two maps form independent
locations on the film were recorded. Location 1 map comprised of 60 x 60 pixels with 0.5
µm step size resulting in the approximately 30 µm x 30 µm mapped area. Location 2 map
consisted of 90 x 60 pixels with 0.5 µm step size resulting in the approximately 30 µm x
45 µm mapped area.
4.4.4

Raman Instrumentation for Solid-State and Particle Sizes Sensing

Solid-State Raman Spectra of Griseofulvin Nanosuspensions: An EZRaman LE
Raman Analyzer System from Enwave Optronics with a HRP 8 high throughput fiber
probe and a 250 mW 785 nm laser focused at a working distance of 6 mm was used for
simulated in-line measurements of crystallinity of griseofulvin nanosuspensions. Raman
spectra were collected with 10 seconds acquisition time each.
Griseofulvin Particles Sizes in Nanosuspensions: EZRaman LE Raman Analyzer
System coupled to MicroVievew adapter with a 4x objectives and 15 µm spot size; and
Mesophotonics SE1000 Raman spectrometer with a 300 mW power 785 nm excitation
laser and 130 µm diameter spot size were used to measure the particle sizes of
griseofulvin in nanosuspensions. Each sample measurement corresponded to an average
of 5 scans, each 10 seconds long, totaling 50 seconds in scanning time.

80
4.4.5

Data Treatment

Data Treatment for NIR Spectra (Films 1-3 and 5): The data were analyzed using the
Malvern NIR Instrument’s Isys vresion 5.0.0.14 software. The logarithm, log10(1/R), was
first applied to the data cube to convert the spectra to absorbance units. Bad pixels were
replaced by the average response of the neighboring pixels. A low-pass Fourier filter was
applied to reduce spectral noise caused by the use of transflectance for a semi-transparent
matrix. The spectra were normalized using the Standard Normal Variate and SavitzkyGolay second derivative (filter order 3, filter width 9) [24].
Data Treatment for Raman Maps: The data were analyzed using the Malvern NIR
Instrument’s Isys version 5.0.0.14 software. Raman spectra were collected in the 850 to
1650 cm-1 frequency range. A spatial mask was initially applied in order to eliminate
background pixels, followed by a low pass filter, baseline correction, normal standard
variate (SNV) transformation and Savitzky-Golay second derivative (filter order 3, filter
width 13). The resulting spectra were obtained from 850 to 1650 cm-1 frequency range.
Partial least squares discriminant analysis (PLS-DA) was performed to provide a
chemical image based on the distribution of the drug throughout the film. For films 6 - 9,
same data pretreatment was applied as above followed by univariate analysis of the 820
cm-1Raman line intensity for the solid-state characterization of the films produced from
griseofulvin nanosuspensions. For film 12C, data processing was performed by using
Jobin Yvon/Horiba LabSPEC 5 version 5.42.18 software. The collected map was
normalized and analyzed using the Direct Classical Least Square (DCLS) technique.
Data Treatment for In-Line Particle Size Raman Spectra: Data collected were
analyzed using Mesophotonics SE1000 Raman instrument’s ACD/Labs SpecManager
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version 12.01 software. All Raman spectra were normalized and smoothed by a SavitzkyGolay filter (order 5, width 11) and analyzed using the univariate method by monitoring
822 cm-1 and 1706 cm-1 Raman lines intensities at each sampling interval. The Raman
line at 822 cm-1 is known to be attributed to cyclohexanone ring stretching vibrations and
disappears with decrease in crystallinity of the sample as reported by Zarow et al [23].

4.5 Sensing of Films and Nanosuspensions
4.5.1

Films

The overall objective of this chapter is to use results of off-line Raman spectroscopic
characterization, such as those described in Chapters 2 and 3, to help interpret on-line
Raman monitoring performed in the test-beds of the ERC. Off-line Raman mapping was
performed for griseofulvin films of various concentrations and analyzed for particle
distribution, quantification and defect formation. In addition, complementary NIR and
Raman chemical analyses were performed for some of the films [24] to investigate the
presence of agglomerates and the solid-state morphology of embedded particles. The
goal of off-line imaging is to provide input to in-line Raman data interpretation
particularly regarding the homogeneity of dosage forms in pharmaceutical films and
tablets. Previous studies have used NIR-CI for polymeric films containing dissolved API
[97] whereas in this study the drug particles are suspended in the matrix. Partial Least
Squares Discriminant Analysis (PLS-DA) and Direct Classical Least Square (DCLS) are
performed to develop a chemical image based on the spatial distribution of the drug
throughout the film for various films [24].
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a) Film 12C
Distribution of griseofulvin particles embedded in a pharmaceutical film is crucial to
determining the optimal preparation conditions and monitoring any morphological
changes during film fabrication. Figures 4.2 (a) and (b) represent Raman chemical maps
and Raman chemical images resulting from data processing of two independently
mapped locations on film 12C with 9.30 wt% API, 69.7 wt% HPMC, 20.9 wt% GLY and
0.02 wt% SDS respectively. Chemical images correspond mostly to the API particles,
shown in light blue or green, and HPMC shown in red. The shades of blue/green indicate
API scattering intensity which changes due to the topology of the film and uneven HPMC
coverage. The mapping data indicate no chemical or structural changes of the API and
shows drug agglomerations into larger particle regions from 5 to 10 µm. There are also
smaller particles of size less than 5 µm.
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Figure 4.2 Raman chemical analysis of film 12C: (a) Raman chemical maps of
griseofulvin distribution for location 1 (top) and 2 (bottom) on the film, and (b) Raman
chemical images developed for location 1 and 2 using DCLS analysis.
b) Films 1, 2, 3, and 5
NIR Mapping – Due to the large overlap between NIR bands for griseofulvin and
HPMC, second derivative spectra were obtained and the absorption band at 2080 nm was
used since it represents an important change of slope in the spectrum of griseofulvin [24].
Figure 4.3 shows resulting NIR chemical images and histograms of griseofulvin films.
Films 1, 3 and 5 show differences in the variation of the distribution in each histogram,
associated with differences in the distribution of HPMC and griseofulvin in the film. The
binary image analysis, not shown here, confirmed the absence of large clusters in the
film. However, in films 1 and 4 the particles are not as widely dispersed as in the other
films. The particles are widely dispersed when the area covered is higher, and more
aggregated when the area covered is reduced [24].
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Figure 4.3 Near IR chemical images and histograms for the different components within
the films 1, 2, 3, and 5 at 2080 nm [24].
Raman Mapping - Figure 4.4 shows Raman spectra of individual film components,
HPMC, griseofulvin, and composite HPMC-griseofulvin film.

The boxed region

indicates the spectral region with the strong 1620 cm-1 griseofulvin band [23]. The
HPMC-griseofulvin film spectra were obtained in spectral regions, as in film 3, where the
1620 cm-1 band intensity is high and HPMC lines are not interfering. Pure HPMC and
griseofulvin spectra from film 3 were used to create a reference library based on partial
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least squares discriminant analysis PLS-DA. The image scores are based on the degree of
association of each pixel with the reference library; higher scores indicate a spectrum
more similar to the loading.

A red-green (RG) color-coded composite image was

developed to show the localization of two components simultaneously. Figure 4.5 (a)
shows the false color spatial mapping for the predicted distribution of API (red) and
HPMC (green) in the four films. The corresponding image represents a sample area of
about 100 µm2 hence providing a high resolution view of the distribution of the API
particles in a smaller area. Higher spatial resolution is therefore obtained by microRaman mapping, and this method could also eventually detect the presence of
inhomogeneity, impurities and/or API polymorphs in the films [98]. The spectra obtained
were compared to those from a prior study where the structural disorder induced by
cryogenic milling and by heating to the amorphous phase in the active pharmaceutical
ingredient were studied using Raman spectroscopy, X-ray powder diffraction (XRPD),
and fluorescence spectroscopy [23]. For griseofulvin films, Raman mapping analysis did
not show any solid-state transition, such as amorphization upon film formation, as
determined by the enhanced intensity of a characteristic Raman line for crystalline
griseofulvin at 820 cm-1 reported by Zarow et al [23].
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Figure 4.4 Raman spectra of griseofulvin, HPMC, and HPMC-griseofulvin. The boxed
region shows lines associated only with griseofulvin.
PLS-DA provided an assessment of drug distribution throughout the films. Table
4.3 summarizes the results showing that the predicted values agree closely with the
nominal concentration values, except for film 2. However, the small area analyzed (≈ 100
µm2) might not be representative of the concentration in the film. Therefore, five
different areas of films 1 and 5 were further analyzed. Table 4.4 shows that the average
value of five measurements is close to the nominal value of the film, however, area 4 in
film 1 and area 2 in film 5 show significant differences between predicted and nominal
concentrations. The results obtained indicate that the sampling error resulting from the
small area analyzed is likely the main reason for the difference in the prediction.
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Table 4.3 PLS-DA Concentration Prediction of Griseofulvin and HPMC in Films 1, 2, 3,
and 5

API
Nominal
API
Predicted

Film 1

Film 2

Film 3

Film 5

57.0%

50.0%

44.4%

36.4%

50.0%

62.0%

44.0%

34.0%

Table 4.4 PLS-DA Concentration Prediction of Griseofulvin in Analyzed Areas of Films
1 and 5
Predicted Value of Griseofulvin
Average

Area 1

Area 2

Area 3

Area 4

Area 5

Film 1

59.0%

55.0%

59.0%

48.0%

54.0%

55.0%

Film 2

33.0%

56.0%

36.0%

36.0%

31.0%

38.0%

Figure 4.5 (b) shows the histograms based on PLS-DA scores for the different films. The
histograms show a very low number of areas with high scores. The high scores are
indicative of high concentrations of HPMC or griseofulvin. However, a large number of
areas are observed where the scores range from 0.4 – 0.6 indicating a lower concentration
of the griseofulvin or polymer. These intermediate concentration values indicate that the
Raman method is detecting both griseofulvin and polymer, and that these are mixed
throughout the film at a fine scale. Raman spectra acquired through high frequency
sampling of the 10 x 10 µm mapping area provided a thorough chemical evaluation. This
type of information is unique to hyperspectral images and is not available from spectra
recorded from sample averaging or integrating spectrometers.
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c) Films 6, 7, 8, and 9
This set of films consisted of films manufactured using various concentrations of
griseofulvin nanosuspensions and dried at different temperatures. It was of great
importance to study the effect of film formation on nanosized drug in suspensions and to
monitor crystallinity and particle size distribution in resulting thin films. Figure 4.6
shows black-white (BW) color-coded composite images developed by monitoring the 822
cm-1 griseofulvin Raman line using univariate analysis where black-white colors
correspond to low and high intensity of the line, respectively. For griseofulvin films
manufactured from nanosuspensions, Raman mapping analysis, at a given resolution, did
not show any solid-state transition, as determined by the presence of the characteristic
Raman line at 820 cm-1 [23]. At this early stage of analysis, it was concluded that the
chemical composition of the drug embedded in the films was not affected by the
manufacturing conditions. Distribution and size of griseofulvin particles could not be
determined at this time since the Raman chemical images showed no individual particles
or agglomerations throughout the mapped areas shown in Figure 4.6.

89
(a)

(b)

Figure 4.5 (a) Red-Green (RG) color-coded Raman images where red represents the
distribution of the API, griseofulvin and green that of the excipient, HPMC; and (b)
Histograms providing quantitative descriptions of griseofulvin and HPMC contents for
films 1, 2, 3, and 5.
Film 6

Film 7

Film 8

Film 9

Figure 4.6 Black (low intensity of the 820 cm-1 Raman line) - White (high intensity of
820 cm-1 Raman line) color-coded Raman images of griseofulvin nanosuspension films 6
through 9 processed with the univariate method.
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4.5.2

Nanosuspensions

The effect of media milling on newly developed stable suspension of griseofulvin of 8.8
wt% nano-sized griseofulvin and HPC-GLY-SDS composites was studied. The stable
suspension at various griseofulvin concentrations was later used to manufacture thin
films by casting. The structural and chemical stability of nanosized drug particles in
formulated suspensions were studied. Media milling was used to increase the
bioavailability of this poorly soluble drug by decreasing its particle size. The previous
study of cryomilled griseofulvin with particle size of the order of 300 nm, resulted in
formation of structural disorder and loss of crystallinity on processing [23]. Since media
milling generated nanosized griseofulvin in a similar size range of approximately 240
nm, it was critical to study the effect of media milling on the solid state properties of
griseofulvin. The structure of the nanosized particles were determined based on the
characteristic Raman lines for crystalline griseofulvin in the 500 to 850 cm-1 spectral
range [23]. An initial study of dynamic and static Raman spectra, collected by a fiber
optic Raman spectrometer to simulate in-line monitoring of the solid-state of the drug in
suspension, showed no indication of an amorphous component in nanosized griseofulvin
in the stable suspension (Figure 4.7).
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Figure 4.7 Simulation of on-line crystallinity monitoring of griseofulvin nanosuspension:
(a) Photograph showing set up for the acquisition of dynamic and static Raman spectra
with a fiber optic Raman spectrometer, and (b) Recorded Raman spectra in dynamic (top)
and static (bottom) modes. Boxed region shows vibrational spectral differences between
amorphous and crystalline griseofulvin.
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The dependence of Raman scattering on particle size has been widely investigated
mostly for inorganic materials. Wang et al [13] studied the intensity of the Raman signal
in pressed powders using a fiber optic spectrometer similar to that employed in this
work, in relation to the particle size for a range of inorganic compounds. They found a
decrease of Raman intensity with increasing particle size which was attributed to
increased diffuse reflectance for larger particles. Iqbal et al found an increase in Raman
linewidths and decrease in peak frequencies in nanoscale silicon below crystallite sizes of
10 nm [99, 100] which is widely recognized today as associated with quantum
localization in nanocrystals and quantum dots. In the present study, the objective was to
investigate the average particle size of griseofulvin in nanosuspensions (with particle
sizes well above the quantum limit but below the size range investigated as referenced) as
a function of milling time by a combination of laser diffraction and Raman spectroscopy.
The intensity of the 1706 cm-1 Raman line increases with decreasing particle size in
agreement with Wang et al due to increased laser light throughput or decreased diffuse
reflectance in suspensions with smaller particles.
Calibration models for particle size prediction of nanosized drug suspensions
were created for multiple sets of data collected with two Raman instruments operating in
the micro and fiber optic modes with different laser spot sizes of 15 µm and 100 µm,
respectively. Different Raman instruments were employed to minimize the influence of
particle size on calibration models. In all data sets, the Raman signal intensity used for
calibration was taken as the difference between the maximum of the 1706 cm-1 Raman
line and a baseline constructed from the minima immediately adjacent to the peak. First
the calibration model was built to determine sensitivity of the instruments by monitoring
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normalized peak intensity as a function of recorded spectrum at each particle size. Mean
values for normalized intensity at each particle size was also calculated. Figure 4.8 shows
a calibration model built for data collected with a laser spot size of 130 µm which
resulted in much better correlation of the signal intensity to the spectrum number, R2 =
0.95 (Mean R2 = 0.97), comparing to data collected with the much smaller laser probe of
a micro-Raman instrument, R2 = 0.67. The variation in the R2 values is mostly related to
the sensitivity of Raman instruments and laser probe spot size. Higher peak noise and
therefore lower R2 (R2 =0.67) value is reported for the instrument with smaller probing
size. Based on the following determination, the remaining collection of Raman data was
performed using the instrument with larger laser spot size. Variation of the peak intensity
was next correlated with particle size values from laser diffraction analysis. Table 4.2
shows D90 and mean values of particle size measurements for griseofulvin
nanosuspension as a function of milling time. For calibration purposes, the D90 value
was used as it represented the particle size for the 90% of the sample. D90 along with
larger laser spot size resulted in a better correlation value when compared to the mean
value and larger laser spot size, R2D90 = 0.94 vs R2MEAN = 0.87 respectively. Figure 4.9
shows the results of the particle size calibration based on intensity of the 1706 cm-1
Raman line for the data set collected with larger, 130 µm laser probe size for D90 and
mean size of griseofulvin particles.
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Figure 4.8 Calibration model representing normalized Raman spectra as a function of
various particle sizes of sampled griseofulvin nanosuspensions: (a) Using all values of
normalized intensity, (b) Using mean values of normalized intensity. Calibration
performed by monitoring 1706 cm-1 Raman line in set of data collected with 130 µm laser
spot size.
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Figure 4.9 Correlation of D90 (top) and mean (bottom) particle sizes with normalized
intensity of the 1706 cm-1 Raman line for griseofulvin nanosuspensions.

4.6 Conclusions
Polymer films loaded with small (low micron or submicron sizes) API particles represent
API composite materials with many possibilities for functionalization and use as drug
delivery matrices in different types of dosage forms. Trapping fine API particles in a
polymeric matrix offers an advantageous way of harvesting engineered particles. The
NIR-CI method provides an image of the spatial distribution of the trapped particles in
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just a few minutes, and is currently being used to optimize the pharmaceutical
formulation and its manufacturing process. Raman mapping on the other hand is being
used to complement NIR-CI as discussed here (currently in a less frequent basis), and its
primary role is to monitor the crystal form of the API, presence of defects and particle
size distributions at the sub-micron level. Raman mapping and NIR-CI are two
complementary spectroscopic techniques, which combined, provide detailed information
about the distribution of API particles as well as chemical detail regarding the interaction
between the drug and the polymer. Raman chemical imaging of thin films fabricated in
an ERC Test Bed for film manufacture from micronized and nanosized griseofulvin
suspensions confirmed the crystallinty of the embedded drug. This can result in even
more innovative film design for poorly soluble drugs like griseofulvin, and can
consequently enhance the dissolution profile and content uniformity of the formulation.
In addition, applications of Raman spectroscopy for particle size and solid-state
monitoring of griseofulvin suspensions during media milling showed that this technique
is capable of on-line quality control during pharmaceutical manufacturing processes.

CHAPTER 5
SURFACE ENHANCED RAMAN SPECTROSCOPY (SERS) OF
PHARMACEUTICAL AND STRUCTURALLY RELATED ENERGETIC
MOLECULES

5.1 Overview
Trace level identification of chemical entities plays an important role in pharmaceutical,
biological and environmental sciences, and in security applications [85, 101, 102].
Typical analytical techniques rely on the use of chromatographic methods (HPLC, GC) to
separate and identify individual components. However, the chemical information
obtained by this identification, is based mostly on UV-visible or fluorescence
spectroscopic data which lack direct structural and molecular information of individual
components of a complex system [103, 104]. Surface enhanced Raman spectroscopy
(SERS) has been shown to be sufficiently sensitive for analytical applications in the
pharmaceutical industry with the capability ultimately of single molecule detection [105,
106].
Discovery of SERS phenomenon was first observed in 1973 by Fleischman et at
[107] who observed strong enhancement of the Raman signal from pyridine molecules
adsorbed on a silver electrode. Few years later, in 1977, the phenomenon was also
independently reported by Jeanmarie and Van Duyne [108] and Albrecht and Creighton
[109]. SERS involves enhancement of the Raman signal via surface plasmons on, for
example, nanostructured gold or silver nanowire substrates. Since the discovery, SERS
has been extensively studied all around the world but much has yet to be learnt about the
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phenomenon. One of the main challenges has long remained in the area of SERS-active
substrate and in particular, its uniformity and reproducibility in detection. Over the past
two decades, however, substantial progress has been achieved in the fabrication of
improved substrates in a highly reproducible fashion due to advances in nanotechnology
which allowed for the fabrication of various new designs [110, 111]. The standard
molecules employed for trace level detection by SERS investigators are various dyes,
such as Rhodamine 6G or crystal violet, [112, 113] used mostly due to their strong
resonance properties, and benzenethiol [110] used due to its ability to form selfassembled monolayers (SAMs) on the SERS active area of substrates.
In this Chapter as part of the overall Raman spectroscopy theme of the thesis, the
primary focus is on the trace detection of key pharmaceutical and structurally related
organics rather than dyes and SAMs that are commonly used by others in SERS studies.
Rather than developing new substrates, the focus will be on SERS detection and
evaluation of one of a few, to the best of the author’s knowledge, commercialized SERS
substrates.
The substrates used are comprised of periodic, photonic crystal arrays of goldcoated, inverted square pyramidal cavities etched on a silicon wafer to induce surfaceenhanced Raman scattering. In this study SERS was used to detect low concentrations of
pharmaceutical compounds: griseofulvin, the active ingredient in antifungal drug, and
acetaminophen or N-acetyl-p-aminophenol (APAP), a common pain medication; and the
aromatic organic energetic compound 2,4,6 trinitrotoluene (TNT), and non-aromatic
organic energetic compounds: 1,3,5-trinitroperhydro-1,3,5-triazine (RDX), and 1,3,5,7tetranitro-1,3,5,7-tetrazocane (HMX). SERS is induced on these substrates by the strong
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interaction of trapped surface plasmons (see section 5.2) within the void architecture of
the cavities with incident visible and near-infrared laser radiation. As discussed below,
highly reproducible surface-enhanced Raman spectra on the SERS-active substrates were
obtained using 785 nm laser excitation at a detection level of 8.8x10-5 M for TNT and
detection levels of 10-4 M for non-aromatic RDX and HMX. A lower detection level of
5.6x10-7 M was achieved for griseofulvin and the lowest, 1.3x10-8 M, was obtained for
acetaminophen. The data for these molecules were compared to those obtained for the
SERS standard dye Rhodamine 6G recorded under the same conditions.
Raman spectra of species at extremely low concentrations are those of the free
molecules since the ordered lattice of a crystalline solid does not exist at that
concentration level [106, 112]. In the case of APAP and griseofulvin adsorbed on the
engineered photonic crystal substrates, the surface enhanced spectra were different from
that of the molecular conformation in their most stable polymorphic forms. However, for
energetic compounds with similar molecular dimensions as the pharmaceuticals, but with
nitro and nitramine groups attached, such as, TNT, RDX, and HMX, the SERS spectra
were essentially the same as the molecules in their known stable crystal forms.

5.2 The SERS Mechanism
Surface enhanced Raman scattering (SERS) when coupled with chemically induced
enhancement due to molecular electronic transitions, is a powerful analytical tool which
can provide chemical and molecular structure information as well as trace level detection
comparable to that achieved by fluorescence spectroscopy [113-116]. Understanding how
the local electromagnetic environment modulates the spectral response in SERS has been
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an area of growing interest since the initial discovery of SERS [107, 108, 117, 118]. It
has become increasingly clear that localized surface plasmons, which are quantized
excitations associated with free electron oscillations in a metal or so-called “hot spots”
from nanostructures like colloidal aggregates or crystal junctions and edges in
nanostructured gold or silver coated substrates give rise to intense local fields that are
responsible for the electromagnetic contribution to SERS [119-121] with enhancements
up to 1012. Another two or three orders of magnitude of chemically-induced enhancement
can occur either due to resonance Raman scattering or from charge-transfer transitions
resulting from the formation of a molecule-metal surface bond. The overall enhancement
factor of 1014 to 1015 therefore makes single molecule detection possible by SERS. “Hot
spots” typically occur at randomly formed locations or fractal structures that can
fortuitously provide the configurations necessary for electromagnetically-induced SERS.
These effects together with variations in surface roughness and particle size on
nanostructured substrates [122] lead to irreproducibility in detection applications.
As a result of improvements in nanofabrication techniques, a number of regularly
ordered periodic nanostructures have been prepared for surface-enhanced Raman
spectroscopy [123, 124]. In spite of these efforts a number of challenges remain,
particularly in the scalable and reproducible production of inexpensive, rugged and
reusable SERS-active substrates. A new class of lithographically fabricated substrates
comprised of a periodically arrayed photonic crystal void architecture capable of
supporting trapped plasmons was initially fabricated by Perney et al [111] and
commercialized as Klarite® by Mesophotonics Ltd (now owned by Renishaw Diagnostics
Ltd). In this chapter the author will discuss the application of these highly robust
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substrates for the SERS detection of low concentrations of the following widely used
molecules:


Griseofulvin and acetaminophen or N-acetyl-p-aminophenol (APAP) used as
active ingredients in the pharmaceutical industry.



Aromatic trinitrotoluene (TNT), and the non-aromatic nitramines: 1,3,5trinitroperhydro-1,3,5-triazine (RDX) and 1,3,5,7-tetranitro-1,3,5,7-tetrazocane
(HMX) used world-wide as the active ingredient in energetic formulations.

The differences in detection limits and surface-enhanced Raman spectra observed for
these compounds and a qualitative explanation for these differences will be provided in
the following sections.
5.3 Klarite® SERS Substrates
Klarite® SERS substrates consist of a periodic square lattice of inverted square pyramidal
pits as shown by the scanning electron microscope image in Figure 5.1 (a). The pits are
produced by conventional photolithography using a silicon dioxide mask on a (100)
oriented silicon wafer. KOH was used to preferentially etch the (111) planes to give a
periodic array of inverted pyramidal pits. The pitch or periodic separation of the pits
formed ranged from 0.7 μm to 1.0 μm. A uniform 300 nm layer of gold was sputtered on
the wafer after completion of the etching process to give a smooth coating on the pit
walls and the flat regions between the pits. The substrate design allows the tunable
plasmon bands to be in resonance with commonly used excitation 632 and 785 nm
wavelengths of Raman spectrometers. The absence of surface Raman enhancement (see
Figure 5.3) from the coating away from the etched pits shows that the overall coating,
even in the pits, is smooth and therefore does not excite SERS. A tapping mode atomic
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force microscope (AFM) image of a gold-coated substrate was obtained using a
Nanoscope III MultiMode Scanning Probe Microscope and shown in Figure 5.1 (b). The
reproducibility of the SERS signal across the active area was investigated by Perney et al
[111].

(a)

2µm
r
h

(b)

Figure 5.1 (a) Top view scanning electron microscope (SEM) image showing 2 m wide
inverted pyramids, and (b) A 10 mm wide atomic force microscope (AFM) image
showing the inverted pyramidal pits of the photonic crystal SERS substrate with a 300
nm thick gold layer. Blow ups of the pits and the region between the pits are shown on
the images to the right.
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5.4 Experimental Details
Raman Spectroscopy: Raman scattering experiments were carried out using a
Mesophotonics SE 1000 Raman spectrometer with a 250 mW near-infrared laser emitting
at 785 nm and a 130 µm diameter spot size. The system operates with an automated XYZ
stage and a video camera for easy visualization of the sample. A typical acquisition time
used was 10 seconds per scanned spectrum with the data averaged over 10 scans.
Preparation of Solutions: Solutions of the pharmaceutical and energetic compounds
under investigation were prepared in high purity solvents (from Sigma Aldrich):
griseofulvin (Sigma-Aldrich) in acetone, APAP (Sigma Aldrich) in acetone, TNT
(obtained from the US Army) in toluene, RDX (obtained from the US Army), HMX
(obtained from the US Army) in acetone, and the SERS standard dye Rhodamine 6G
(Lambda Physik). For each compound, the stock solution was made first and diluted by a
factor of ten each time to obtain further dilutions. For example in the case of
acetaminophen, the stock solution concentration was 20 mg/ml (0.13 M); it was diluted to
obtain concentrations of 2 mg/ml (1.3×10-2 M), 0.2 mg/ml (8.81×10-3 M), 0.02 mg/ml
(8.81×10-4 M), 0.002 mg/ml (8.81×10-5 M), 0.0002 mg/ml (1.3×10-6 M),0.00002 mg/ml
(1.3×10-7 M), and 0.000002 mg/ml (1.3×10-8 M). A micro-pipette was used to deposit
0.1 µl of solution on the active region (Figure 5.1) and allowed to dry quickly at room
temperature in air. The spectrum of a pristine SERS substrate was similarly recorded;
baseline subtracted from the raw data and processed using the ACDLABS 10.0 software
from Mesophotonics, to obtain the spectra shown.
Amorphous griseofulvin was prepared by melting a small amount of crystalline
griseofulvin on a glass slide heated on a hot plate at 220ºC until completely melted, and
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cooled at room temperature to form a solid film. The Raman spectrum of amorphous
griseofulvin was recorded immediately upon solidification of the film. The appearance of
a strong peak at 656 cm-1 and the absence of a peak at 820 cm-1 in the spectrum was used
to confirm the formation of amorphous griseofulvin.[23] The same procedure was used
for preparing amorphous acetaminophen and obtaining its Raman spectrum.

5.5 The SERS Enhancement Factor (SERS EF)
The effectiveness of the Klarite substrate was determined by measuring the enhancement
factor (EF) expressed by the following equation [125]:

SERS EF [Raman Shift (cm-1)] =

Nvol  ISERS
NSERS  Ivol

(5.1)

Nvol – Number of molecules in the probed volume area
Nsers – Number of molecules in the probed SERS substrate area
I vol – Intensity of the Raman signal from the probed volume
Isers – Intensity of the Raman signal form the SERS substrate.
To determine SERS EF, the limit of detection for all investigated molecules was
measured by both conventional and surface-enhanced Raman spectroscopy and compared
with that for Rhodamine 6G (R6G), which was used as a SERS standard in this study.
Using conventional Raman spectroscopy, the lowest level of detection for R6G
solution was determined to be 0.001004 mol/L or 1x10-3 M which corresponded to the
4.1 x 1013 number of molecules (Nvol) in the given volume of the probed solution (Vbeam)
and was calculated as follows:
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Vbeam =

4 3 4
r   (6.5  10  3 cm3 )3  6.5  10 7 ml
3
3

Nvol = 1x10  3 M  6.022  10 23 

6.5  107 ml
 4.1  1013
10ml

The intensity of the Raman line (Ivol) was calculated by integrating the area under the
spectral peak recorded for the lowest detectable concentration by conventional Raman
measurement. Ivol for R6G was found to be 7533 counts/seconds.
For surface-enhanced Raman spectroscopy, the lowest detectable concentration
for R6G was measured to be 0.001004 x 10-6 mol/L or 1.x10-9 M. Similar calculations
were followed for the SERS probed volume (VSERS) to calculate the number of molecules
in that volume (NSERS). SERS volume (VSERS) was calculated based on the substrate area
probed by the laser, the number of wells probed in that area and their corresponding
volumes [Figure 5.1 (a)]. For the number of wells probed:
Wells probed =

Alaser
 3318
Awell

Since, the volume of each well corresponds to:
Vwell =

Ah
 0.9m3
3

Then, the volume probed by the laser beam on the SERS substrate is:
VSERS = 0.9m3  3318wells  3.1  10 9 ml
This corresponds to the number of molecules probed on SERS substrate given by:
3.1  109 ml
 1.9  105
NSERS = 1x10 M  6.022  10 
10ml
9

23

The SERS intensity (ISERS) was calculated in similar fashion as Ivol except the
integrated area under the spectral peak corresponded to the lowest detectable
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Table 5. 1 Enhancement Factors and Contributing Concentrations of Probed Compounds
to the SERS Recorded Spectra

Compound

Enhancement Factor

Limit of Detection (M)

R6G
TNT

1.0x108
6.1x105

1.1x10-9
8.8x10-5

Griseofulvin
APAP

1.2x108
5.4x108

5.6x10-7
1.3x10-8

concentration of each of the investigated compounds using the SERS substrate.
Rhodamine 6G gave an enhancement factor of 108 from equation 5.1 as listed in Table
5.1 together with enhancement factors for TNT, griseofulvin and APAP. Enhancement
factors for HMX and RDX were not obtained because for safety and security reasons
only limited amounts of these compounds were available.

5.6 Raman Spectra of Investigated Molecules on the SERS Substrates

Surface enhanced Raman spectra of griseofulvin, APAP, TNT, RDX, and HMX were
taken on the SERS substrates described above using near-infrared excitation at 785 nm.
The goal of this work was to examine and evaluate the spectra obtained and determine
the SERS sensitivity and enhancement factors using this new generation of photonic
crystal substrates. The highly ordered array of inverted square pyramids covered with
gold results in highly reproducible Raman signals at low analyte concentrations. The
substrate design supports the generation of surface plasmon standing waves localized
inside the bottom of each pit, its sidewalls and the connecting surface bridges between
the pits [Figure 5.1 (a)]. As a result, the electromagnetic fields are found along the
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surface bridges and inside the inverted pyramidal pits [111] leading to effective increase
in magnitude of both incoming radiation and scattered fields. The total SERS
enhancement is a product of two mechanisms as mentioned above: electromagnetic field
(EF) enhancement from the strong coupling between the surface plasmons on the
substrate and molecular vibrational excitations, and chemical enhancement (CE)
associated with the more localized molecule-surface charge transfer interaction [11]. The
surface irregularities of the SERS substrate can significantly affect the enhancement
factor and reproducibility but are minimized in the photonic crystal substrates used here
by engineering of the pit structure. Reproducibility of the Raman signal across the
substrate is reported with less than 10% RSD for a substrate with SAMs of benzenethiol
[111]. Reports using SAMs model systems for a range of SERS substrates show a high
degree of reproducibility [110, 126]. The results have been used to understand the
selective enhancement or loss of intensity of Raman lines by identifying moleculesubstrate orientation [127, 128]. SAMs result in monolayer surface bonding which
strongly influences the homogeneous distribution of the molecules on a SERS substrate
to provide more controllable electromagnetic enhancement. Other studies, however, have
shown that this selectiveness in enhancement of Raman lines can be attributed to
increased Raman scattering cross sections caused by changes in molecular electronic
structure due to surface bonding rather than molecular orientation vis-a-vis the substrate
[11, 126, 129]. Examining the behavior of various organic compounds discussed below
on the arrayed photonic crystal SERS substrates, it is noticed that some of the SERS
Raman spectra vary from that of the bulk material. A possible explanation for this
behavior is discussed.
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TNT

The Raman spectrum for solid TNT in the 200 to 2000 cm-1 fingerprint region is shown
in Figure 5.2 (A). Important spectral features consist of a somewhat broadened, intense
line peaked at 1362 cm-1 assigned to the symmetric stretching -NO2 mode of the TNT
molecule, a doublet at 822 cm-1 and 791 cm-1 assigned to scissoring and wagging motions
respectively of the -NO2 groups, and lines at 1618 cm-1 and 1535 cm-1 assigned to the
aromatic C=C stretching and asymmetric stretching -NO2 modes, respectively [130]. The
broadening of the line due to the symmetric stretching -NO2 mode is due to unresolved
splitting of this mode caused by a breakdown of the ring symmetry in TNT due to
electron donation of the methyl group to the aromatic ring [130]. The lines between 822
and 1362 cm-1 can be assigned to in-plane ring bending, CH3 deformation and C-N
stretching modes of TNT, whereas the lines below 791 cm-1 can be contributed to out-ofplane ring bending, ring distortion and C-CH3 wagging modes [131].
(A)

(B)

(a) 8.81 x 10M

-3

(b) 8.81 x 10M
(c) 8.81 x 10M

-4

-5

(d) 8.81 x 10M

-6

Figure 5.2 (A) Background-subtracted solid TNT spectrum with its molecular structure
attached, and (B) SERS from samples prepared by evaporating 0.1 µl solutions of various
concentrations of TNT in toluene. 785 nm laser radiation and 10 seconds acquisition time
were used for recording the spectra for: (a) 2 mg/ml or 8.81x10-3 M solution, (b) 0.2
mg/ml or 8.81x10-4 M solution, (c) 0.02 mg/ml or 8.81x10-5 M solution and (d) 0.002
mg/ml or 8.81x10-6 M solution.
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Background-subtracted, 10 seconds SERS Raman spectra in the 100 to 2000 cm-1
range taken from the active region of the SERS substrates from TNT solutions of
different concentrations in toluene down to 0.002 mg/ml or 8.81x10-6 M, are shown in
Figure 5.2 (B). All Raman features are evident in the 0.02 mg/ml spectrum while the
stronger Raman features of solid TNT are discernable in the 0.002 mg/ml spectrum which
is equivalent to 8.81 x 10-6 M TNT in toluene. The weaker features of the 0.002 mg/ml
spectrum, however, become evident at higher integration times. It is estimated that the
level of detection for TNT is about 0.002 mg/ml solution or 8.8 x 10-5 M. The
enhancement factor of 105 is calculated for TNT using equation 5.1 above as listed in
Table 5.1. No Raman spectra at these low concentration levels are observed from the flat
inactive region of the substrate away from the inverted square pyramidal cavities.
Comparison of the solid to the SERS Raman data indicates that the overall
spectral distribution of the lines is the same. This is also true for data recorded using
632.8 nm excitation. Small shifts in line positions are however observed in the SERS
data. For example, the line at 1362 cm-1 in the solid state spectra assigned to the
symmetric -NO2 stretching mode shows a highly reproducible down-shift in the SERS
data by 3-5 cm-1 probably due to the absence of strong intermolecular interactions in the
dilute phase sampled by SERS.

RDX and HMX

The Raman spectra for highly pure solid RDX and the stable -polymorph of HMX used
in this study are shown in the 250 to 2000 cm-1 fingerprint region in Figures 5.3 (A) and
5.4 (A), respectively. The spectra consist of a complex pattern of several more intense
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lines than those in the same region for TNT. The lines in the 250 to 800 cm-1 region for
both RDX and HMX can be assigned to ring deformation, NO2 scissoring, rocking and
wagging motions [132, 133]. The strongest line is at 882 cm-1 in RDX and at 832 cm-1 in
the larger HMX molecule. In RDX this line can be assigned to a mode consisting of C-N
stretching, N-N stretching and –CH2 rocking [132]. There are also two nearby intense
lines in HMX at 879 and 949 cm-1 which been assigned to ring breathing or stretching
modes in HMX by Iqbal et al [133] and in RDX by Ciezak and Trevino[132]. The line at
1309 cm-1 in RDX and at 1311 cm-1 in HMX, and lines between 1500 and 1600 cm-1 in
RDX and HMX can be assigned to the symmetric and asymmetric stretching modes,
respectively, of the -NO2 groups [133].
The surface-enhanced Raman spectra for RDX and HMX taken from the SERS
active region of the substrate are shown in Figures 5.3 (B) and 5.4 (B), respectively. The
limit of detection of the primary Raman lines is 0.1 g/ml or 4.5 x 10-4 M which is about
two orders of magnitude higher or less sensitive than the limit of detection for TNT. This
suggests that the plasmon-phonon coupling responsible for SERS is much higher for the
aromatic TNT molecule with more delocalized electrons. Moreover, the surfaceenhanced spectra of RDX and HMX have fewer lines relative to the solid state spectra,
probably because the spectra are in the highly dilute molecular phase and therefore the
strong intermolecular hydrogen bonding, O∙∙∙O and O∙∙∙C interactions present in the solid
are absent. The strongest Raman line at 882 cm-1 in solid RDX downshifts by 6 cm-1
similar to the behavior observed for the -NO2 symmetric stretching mode in solid TNT
which is the strongest Raman line in the TNT spectrum. In HMX however the line at 949
cm-1 downshifts by 12 cm-1 whereas the line at 832 cm-1 increases in frequency by
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(A)

(B)

(a) 4.5 x 10-3M
-4
(b) 4.5 x 10 M
-5

(c) 4.5 x 10 M

Figure 5.3 (A) Background-subtracted solid RDX spectrum with its molecular structure
attached and (B) SERS from sample prepared by drying 0.1 µl solutions of various
concentrations of RDX in acetone, using 785 nm laser radiation and 10 seconds
acquisition time: (a) 1 mg/ml or 4.5 x 10-3 M solution, (b) 0.1 mg/ml or 4.5 x 10-4 M
solution, and (c) 0.01 mg/ml or 4.5 x 10-5 M solution.

(A)

(B)

-3

(a) 3.3 x 10 M

-4

(b) 3.3 x 10 M
-5

(c) 3.3 x 10 M

Figure 5.4 (A) Background-subtracted solid -HMX spectrum with its molecular
structure attached, and (B) SERS from sample prepared by evaporation of 0.1 µl
solutions of various concentrations of -HMX in acetone, using 785 nm laser radiation
and 10 seconds acquisition time: (a) 1 mg/ml or 3.3 x 10-3 M solution, (b) 0.1 mg/ml or
3.3 x 10-4 M solution, and (c) 0.01 mg/ml or 3.3 x 10-5 M solution.
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12 cm-1 due to structural renormalization in the molecular phase. Another interesting
feature is that the line assigned to the -NO2 symmetric stretching mode increases in
frequency relative to the solid in SERS both for RDX and HMX by 5 to 7 cm-1 in contrast
to the behavior of the corresponding mode in TNT where there is a downshift.

Griseofulvin

The Raman spectrum of solid griseofulvin in the 100 to 210 cm-1 region are shown in
Figure 5.5 (A) and are in agreement with the spectrum reported by Zarow et al [23].
Griseofulvin is an aromatic organic but unlike TNT does not have strongly
electronegative nitro substituent groups.

A series of background-subtracted SERS

Raman spectra of drop deposited griseofulvin of concentrations down to 0.0002mg/ml or
5.6 x10- 7M and the normal Raman spectrum of amorphous griseofulvin, are shown in
Figure 5. 5 (B). The enhancement factor of 108 was calculated based on equation (5.1)
and is shown in Table 5.1. Characteristic Raman lines for the SERS spectra of
griseofulvin molecules show major differences when compared to the Raman spectra of
solid, crystalline griseofulvin as shown in Table 5.2. A detailed examination of all SERS
spectra shows strong resemblance of these spectra with the normal Raman spectrum of
amorphous griseofulvin. Upon crystalline-to-amorphous transition, the distinctive Raman
line at 820 cm-1 corresponding to the cyclohexanone ring stretching mode is completely
lost [23] which is also the case for the SERS spectra. In addition, the triplet in the 650
cm-1 spectral region of the crystalline form transforms into a broad singlet at 646 cm-1 in
the SERS spectra. The lines for the –CH in-plane deformation in the solid state Raman
spectra show a highly reproducible 2 to 5 cm-1 upshift in the SERS data and are more
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intense than the corresponding Raman lines in amorphous APAP discussed below.
Similar frequency upshifts are observed for the -CH3 and -CH2 deformation, and C=O
and C=C stretching modes as summarized in Table 5.2 which indicate increases in C-H,
C=O and C=C bond force constants on going from the crystalline to the molecular state.
Increases in line frequencies are also seen in part on going from the crystalline to the
amorphous phase since the amorphous phase of an organic can be considered to be a
frozen liquid with randomly oriented molecules and no long range inter-molecular
coherence [25].
Even though the EF for griseofulvin and APAP are of the same order (108), the
corresponding detection sensitivities are different, 10-7 M versus 10-8 M, respectively.
This can be related to the presence of electron withdrawing and donating groups on the
respective aromatic benzene rings in each of the molecules which can influence the
electron density on the ring. In griseofulvin, the presence of an -OCH3 moeity can result
in transfer of some of the substituted group electrons to the ring via a resonance effect.
On the other hand, in case of griseofulvin, the presence of a strong electronegative -Cl
group (similar to –NO2 groups in TNT) will promote withdrawal of ring electrons via the
sigma bond to decrease electron density on the aromatic ring. In the case of APAP,
however, the aromatic ring is bonded to electron donating groups, –OH and –H-N-C=O
and hence electron density on the aromatic ring will increase, resulting in increased
coupling with surface plasmons and higher SERS sensitivity in agreement with
experimental results.
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(A)

(B)

Amorphous
-2

(a) 5.6 x 10 M
-4

(b) 5.6 x 10 M
-5

(c) 5.6 x 10 M
-6

(d) 5.6 x 10 M
-7

(e) 5.6 x 10 M

Figure 5.5 (A) Solid spectrum of griseofulvin with its molecular structure attached, (B)
SERS from sample prepared by evaporating 0.1 µl solutions of various concentrations of
griseofulvin in acetone, using 785 nm laser radiation and 10 seconds acquisition time: (a)
20 mg/ml or 5.68 x10-2 M solution, (b) 0.2 mg/ml or 5.68 x10-4 M solutions, (c) 0.02
mg/ml or 5.68 x10-5 M solution, (d) 0.002mg/ml or 5.68 x10-6 M solution and (e) 0.0002
mg/ml or 5.68 x10-7 M solution. Top Raman spectrum shows melt-quench amorphous
griseofulvin.
Table 5.2 Raman Frequencies and Qualitative Mode Assignments in Crystalline,
Amorphous and SERS Griseofulvin
Crystalline
Amorphous
Frequency (cm-1) Frequency (cm-1)
428
426
628
647
650
820
967
968
1178
1178
1217
1213
1239
1238
1350
1349
1613
1618
1663
1659
1706
1707

SERS
Frequency (cm-1)
428
646
968
1181
1220
1242
1354
1614
1663
1709

Qualitative Assignments
C-Cl deformation
C-Cl stretching, ring deformation
C-Cl stretching
Cyclohexanone ring stretch
Benzene ring asymmetric stretch
Ring vibration, -C-O-C stretch

-CH in-plane deformation
-CH in-plane deformation
- CH3 and -CH2 deformations

C=O mixed with C=C stretch
C=C stretch in cyclohexanone
C=O stretch in benzofuran
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Acetaminophen (APAP)

APAP, which is a purely aromatic molecule like griseofulvin, can exist in three
polymorphic forms besides its solid amorphous phase [73]. The monoclinic yype I phase
crystallizes as the most thermodynamically stable form. Its solid Raman spectrum in this
stable phase in the 200 to 2000 cm-1 fingerprint region is shown in Figure 5.6 (A). The
characteristic Raman lines at 1650 cm-1 and 1616 cm-1 are assigned to the C=O stretching
and the N-H deformation modes, respectively, as indicated in Table 5.3. The line at 1562
cm-1 is attributed to the H-N-C=O amide carbonyl group vibration, the line at 1324 cm-1
to the C-H bending mode whereas the line at 1169 cm-1 is due to the C-H deformation
vibration. The strongest Raman lines are in the 800 cm-1 spectral region where
characteristic modes for the phenyl ring stretch and aromatic C-H out of plane vibration
exist at 796 cm-1 and 856 cm-1 respectively [74, 84].
Surface enhanced Raman spectra of APAP taken from the active region of the
substrate show noticeable differences from the solid Raman spectra of the drug mainly
because as in griseofulvin, the SERS spectra correspond to those of APAP molecules.
The limit of detection for the primary enhanced line at 856 cm-1 is 2 x 10-6 g/ml or 1.3 x
10-8 M, which gives an enhancement factor of 108 based on equation (5.1). The C=O
stretching, N-H deformation and HN-C=O bending-stretching modes of the solid Raman
spectrum are very weakly enhanced and can be only detected at high concentrations of 2
mg/ml and cannot be observed for further dilutions as shown in Figure 5.6 (B). It is
interestingly noticed that the strongest enhancement is recorded for the mode
corresponding to the aromatic phenyl ring vibrations in the 800 cm-1 region. The SERS
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(A)

(B)

(a)

Amorphous
-2

(a) 1.32 x 10 M
-4

(b)

Crystalline

(b) 1.32 x 10 M
(c) 1.32 x 10-6M
-8

(d) 1.32 x 10 M

Figure 5.6 (A) Normal Raman spectrum of (a) solid and (b) amorphous acetaminophen
with molecular structure attached, and (B) Background-subtracted SERS spectra from
sample prepared by evaporating 0.1 µl solutions of various concentrations of
acetaminophen in acetone, using 785 nm laser radiation and 10 seconds acquisition time.
The SERS spectra are for: (a) 2 mg/ml or 1.32 x 10-2 M, (b) 0.02 mg/ml or 1.32 x 10-4 M
solution, (c) 0.0002 mg/ml or 1.32 x 10-6 M solution, (d) 0.000002 mg/ml or 1.32 x 10-8
M solution.

spectral features resemble the normal Raman spectrum of amorphous acetaminophen as
in griseofulvin, indicating the absence of intermolecular interactions.

The highly

reproducible up- and down-shifts of several Raman lines in the SERS spectra are
summarized in Table 5.3. The strongest Raman line at 856 cm-1 upshifts by 4 cm-1 similar
to the behavior of the C-H out-of-plane bending mode for amorphous APAP. The
remaining Raman lines in the SERS spectra show 2 cm-1 to 5 cm-1 downshifts and agree
with shifts of these lines on going from the crystalline to the amorphous phase. Two
Raman lines, however, show even higher downshifts than the corresponding amorphous
phase Raman lines. These lines are the out-of-plane deformation mode at 326 cm-1 which
decreases in frequency by 5 cm-1 in the SERS spectra, whereas only a 2 cm-1 downshift is
seen for this line in the amorphous phase. Similarly to -N-H deformation mode at 1616
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cm-1 decreases in frequency by 5 cm-1 in the SERS spectra and only 2 cm-1 in the
spectrum of the amorphous phase. This trend is opposite to what is seen in griseofulvin,
where most of the SERS lines showed upshifts suggesting increases of the interatomic
force constants. This behavior may be associated with differences in molecular structure
(see discussion in griseofulvin section).
Table 5.3 Raman Frequencies and Qualitative Mode Assignments in Crystalline,
Amorphous and SERS Acetaminophen
Crystalline
Frequency (cm-1)
326
388
462
501
649
796
856
1169
1237
1278

Amorphous
Frequency (cm-1)
324
382
502
643
794
859
1167
1231
1273

SERS
Frequency (cm-1)
321
382
499
643
794
859
1166
1230
1273

1324
1371
1562
1616
1650

1321
1372
1614
1660

1320
1369
1611
-

Qualitative Assignments
Out-of-plane ring deformation
Out-of-plane ring deformation
Out-of-plane ring deformation
In-plane ring deformation
phenyl ring stretch [74]
C-H out-of-plane bend
C-H in-plane bend
C-N stretch
O-H and C-O combination, (ar) C-N
stretch
C-H bend
-CH3 umbrella mode
-H-N-C=O stretch [74]
-N-H deformation [74]
C=O stretch [74]

5.7 Conclusions

The results presented here using SERS substrates comprised of arrays of inverted
pyramidal pits for three types of energetic and pharmaceutically active organic molecular
crystals show that the SERS detection sensitivity or enhancement factor is the lowest for
the non-aromatic nitramine compounds RDX and HMX and nitro-substituted aromatic
TNT, where the enhancement factor approaches 106. Increase of enhancement factors by
another 2 orders of magnitude is achieved for purely aromatic pharmaceutical molecules
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griseofulvin and APAP, and also for the dye molecule Rhodamine 6G. The enhancement
factors achieved are however many orders of magnitude lower than single molecule
detection levels near 1014 achieved for dye molecules on “hot spot” sharp nanoscale tips
or between nanometer-spaced nanoparticles. On the other hand since the plasmons are
localized within cavities in the SERS substrates used, the plasmon field distributions are
matched to reach deep inside the mid-sized molecules probed here to provide, unlike for
“hot spot” nanostructures, a high degree of reproducibility of the spectral signals
obtained.

CHAPTER 6
SUMMARY, CONCLUSIONS AND SUGGESTED FUTURE WORK

The work discussed in this thesis is focused on themes related to the application of
Raman spectroscopy as a sensing and non-destructive characterization tool for use
primarily in the pharmaceutical industry. Although the complementary tool of near
infrared spectroscopy is more widely used in this industry, Raman techniques involving
fiber optics are slowly emerging as a methodology to provide not just sensing but also
molecular and crystal phase science that are of critical importance for quality-controlled
drug manufacture.
In Chapter 1, an introduction and a brief overview of the quality requirements
involving PAT (Process Analytical Technology) initiative, was presented with an
emphasis on real time quality control and better understanding of novel materials down to
the nanoscale level. The analysis of manufactured products requires some of the most
effective and information-rich tools of solid-state science. Raman spectroscopy, as a
highly advanced, molecule-specific method, was presented in its theoretical aspects and
shown to be an excellent method for this task, particularly for the challenges of
understanding molecular interactions in complex solids. Complementary methods used in
this work were also briefly discussed.
Structural disorder induced by cryogenic milling and by heating to the amorphous
phase in the active pharmaceutical ingredient, griseofulvin primarily studied by Raman
spectroscopy with contributions from small (using Synchrotron techniques) and wide
angle X-ray powder diffraction (XRPD), fluorescence spectroscopy and differential
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scanning calorimetry (DSC) are presented in Chapter 2. A broad, novel frequencyindependent scattering background superimposed on the Raman spectra observed
together with changes in intensities and splittings of some of the Raman lines due to
lattice (inter-molecular) and molecular modes are interpreted and discussed in detail. In
the cryomilled samples this strong background can be deconvoluted into two
components: one due to lattice disorder induced by cryomilling and the other due to Mie
scattering from nanosized crystallites. Related but more intense background scattering for
thermally produced amorphous griseofulvin can be fitted to a single Lorentzian function
and attributed to lattice disorder. Comparison of Raman and fluorescence data showed no
relation of the Raman background intensity to impurity- or molecular defect- induced
fluorescence as fluorescence measurements showed an intrinsic fluorescence signal in asreceived griseofulvin that does not correspond to the inelastic background in the Raman
spectra, and moreover decreases in intensity on cryomilling. Broad two-component
background scattering for cryomilled griseofulvin was also observed by wide-angle
XRPD measurements and attributed to lattice disorder but at much longer correlation
lengths than in Raman scattering. Disorder at two correlation lengths indicated by the
XRPD data was consistent with the background scattering components in the Raman data
associated with lattice disorder and Mie scattering. Persistence of this disorder to even
longer lengths is evident in small-angle Synchrotron XRPD data on micronized
griseofulvin taken as a function of temperature from the crystalline to the amorphous
phase. Effective identification of process induced structural disorder is likely to be an
important aspect of pharmaceutical formulation manufacturing. Disordered domains
formed can progressively transform during processing into long range disorder and result
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in polymorphs or amorphous phase formation that would impact the quality of the dosage
form produced.
Different aspects of polymorphism of the widely used model drug acetaminophen
(APAP) are considered in Chapter 3. Also in this chapter and in the related Appendix A,
the molecular and lattice vibrations observed in APAP in its various forms and type I
APAP in single crystal form, respectively, were measured and interpreted. Oriented
single crystal Raman data and its temperature dependence were measured for the first
time to the best of our knowledge in order to understand milling behavior. APAP exists in
three different crystalline arrangements and a disordered amorphous form. The type II
polymorph is of potential pharmceutical interest due to its better tabletting characteristics
relative to the stable type I polymorph – however, as normally prepared, it is not stable
enough for long term use as a pharmaceutical product. In this research new interfaces
were successfully created in type I APAP by micronization and by dry-coating with
nanosized silica to significantly extend the stability of type II obtained from this modified
type I phase. Raman spectroscopy, and XRPD, SEM and dissolution techniques were
employed to monitor and characterize the stabilized phase. One interesting result
obtained was that with increasing time a diffuse scattering background appeared in the
Raman spectra which varied with time. This scattering is similar to what was seen in
cryomilled griseofulvin and was qualitatively attributed to the slow growth and annealing
of nanosized nuclei of the stable type I polymorph in the matrix of the stabilized type II
APAP phase at ambient conditions. Intrinsic dissolution data were also measured and
showed an improvement in mass release for type II APAP obtained from micronized and
nanocoated type I APAP.

122

Raman sensing and imaging of pharmaceutical dosage and manufacturing forms,
involving the model API griseofulvin, are the topics discussed in Chapter 4. Monitoring
of thin gel griseofulvin films fabricated from micronized powders and nanosuspensions
provided analytical process understanding of molecular interactions at the micro- and
nano-scale. Findings and scientific understanding, such as those described in Chapters 2
and 3, were used to help interpret off-line Raman mapping of these novel dosage forms.
Raman mapping complemented by near infrared chemical imaging (NIR-CI), was used to
investigate solid-state morphology and agglomerates of the embedded particles in the
polymeric matrix of the gel. NIR-CI provides scrutiny at comparatively larger scales than
Raman imaging, to show the absence of large clusters and various degrees of drug
dispersion and aggregation throughout the film area covered with the drug. Raman
imaging evaluated dispersion at sub-micron levels and confirmed crystallinity of the
embedded drug for films fabricated with micronized and nanosized griseofulvin
suspensions based on the presence of characteristic Raman lines for crystalline
griseofulvin in the 500 to 850 cm-1 spectral range. The use of fiber-optic Raman
spectroscopy for particle size characterization was developed for in-line monitoring of
griseofulvin nano-suspensions with 300 nm sized particles obtained by media milling.
The crystallinity of the suspensions and size prediction based on Raman signal intensity
showed the capability of this technique for on-line quality control during pharmaceutical
manufacturing.
Chapter 5 discusses the use of Raman spectroscopy for sensing down to trace
levels of organic pharmaceutical and energetic solids. Photonic crystals in the form of
periodic arrays of gold-coated, inverted square pyramidal cavities etched on a silicon
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wafer were used to induce surface-enhanced Raman scattering (SERS) to detect trace
concentrations of purely aromatic pharmaceutical compounds griseofulvin and APAP;
non-aromatic nitramine compounds 1,3,5-trinitroperhydro-1,3,5-triazine (RDX) and
1,3,5,7-tetranitro-1,3,5,7-tetrazocane (HMX) and nitro-substituted aromatic 2,4,6
trinitrotoluene (TNT). For griseofulvin and APAP, amorphous-like Raman spectra were
observed at trace levels (enhancement factor of 108-109) whereas the energetic
compounds with much lower enhancement factors showed Raman spectra corresponding
to their crystalline phases with correlated molecules. This suggests that the amorphous
phase in organics corresponds to uncorrelated molecules in a matrix, although the
experimental conditions here are well below the single molecule detection limit of about
1014. It was also shown that since SERS is induced on these substrates by the strong
interaction of trapped surface plasmons within the micron-scale void architecture of the
cavities a high degree of reproducibility of the detected signals is obtained unlike for socalled “hot spot” conditions for single molecule level detection.

FUTURE WORK:

The following are some topics for future work related to this thesis:


Quantitative understanding of the broad inelastic scattering in defected organic
solids by modeling and simulations



Thermal measurements, such as differential thermal calorimetry to determine
molar heat capacity and understanding the driving force for stabilization of the
type II polymorph of APAP
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Fabrication of tablets by compaction of stabilized type II APAP and use of Raman
spectroscopy and imaging techniques to evaluate long-term stability



Further analysis of images obtained for films fabricated from API (e.g.
griseofulvin) nanosuspensions would test for precision and accuracy of the
predictions of component concentrations in thin films and extend it to excipient
tablets with deposited API. It would also be of interest to develop in-line sensing,
other than chemical imaging used till now, to characterize film quality during
production and further optimization of already developed in-line monitoring of
particle size of API in nanosuspensions by Raman spectroscopy to effectively
predict the particle size during milling.

APPENDIX A
APAP SINGLE CRYSTAL STUDY

Using Raman spectroscopy, as discussed in this thesis, lattice and molecular vibrational
data can be obtained. Although it is not typically done, it would be particularly useful if
this data can be collected from individual crystals as a function of temperature, pressure
and crystal orientation. During pharmaceutical processing of organic powders consisting
of millions of crystallites, mechanical milling is often used to decrease the average
particle size of weakly water-soluble particles in order to provide solubility. Thermal and
pressure changes that occur during the milling process can induce structural
transformations in the milled powders. A temperature and pressure study of a single
crystal simulates these changes for an individual pharmaceutical crystallite in a powder to
provide insights into the intra- and inter-atomic forces within the crystal structure. This is
part of a larger study within the NSF-ERC which includes single crystal X-ray diffraction
as a function of uniaxial stress at the University of Hawaii coupled with modeling at
Rutgers University. In this work single crystals of acetaminophen (APAP) grown at the
University of Hawaii (K. Morris et al) have been studied as a function of temperature up
to near the melting point and crystal orientation using confocal Raman spectroscopy to
better understand the effect of milling on structural stability and the possibility of
inducing polymorph formation. In addition, Raman spectra recorded as a function of
crystal orientation (determined by the Hawaii group) and structural data in the literature
on the molecular architecture in the stable type I polymorph allowed more explicit
assignments

to

modes

of

the

molecular
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and

lattice

vibrations.
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Figure A.1 (a), (b), and (c) shows confocal micro-Raman spectra at ambient
conditions from the main three faces of a rod-like monoclinic single crystal with 4
molecules per unit cell and P21/a space group symmetry [65] compared with the
corresponding Raman spectrum of powders of type I APAP. Each face will correspond to
a unique set of orientations of the APAP molecule in the type I polymorphic structure.
Figure A.2 (a), (b), and (c) show spectra qualitatively attributed each to one of the main
faces with Miller indices of (001), (020), and (20 1 ) determined by X-ray diffraction.
The intensity of a Raman line depends on the interaction of the electric vector of the
incoming radiation with the vibrational eigenvector. The most intense vibration would be
one where the two vectors are in the same plane.
Figure A.1 (a) shows Raman spectra from single crystal APAP with the laser
beam backscattered from the crystal face labelled face 1 and from APAP powder. The
Raman spectrum of the powder represents the average Raman scattering from crystallites
of various orientations. Strong Raman intensity values indicate that the inter- and intramolecular vibrations in acetaminophen, particularly the arrowed lines associated with the
stretching of the aromatic ring, aromatic C-H stretching and C=O vibrations show high
intensity because they are in the plane of the electric vector of the incident exciting laser
beam. This is consistent with the molecules being oriented in the (020) plane as shown in
the insets to Figure A.1 (a). Figures A.1 (b) and (c) show the Raman spectra for faces 2
and 3 of the single crystal. The Raman intensity distribution for face 2 is substantially
reduced relative to that of the powder spectrum. This face can be assigned to the

(20 1 ) plane because the aromatic rings in this plane, as shown in the inset, are aligned
approximately edge-on to the incident beam and therefore only the weaker deformation
126
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vibrations interact with the electric vector of the incident beam. Face 3 can be assigned to
the (001) plane because the Raman intensity distribution from this face is similar to that
of the powder due to the fact that the APAP molecules have an intermediate alignment
and the electric vector of the incident laser beam interacts with both stretching and
deformation vibrations.
(a)

c

a

b

(020) Plane

Molecular arrangement in
(020)
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(b)
c

b

a

(20 1 ) Plane

Molecular arrangement in (20 1 )
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(c)

c

a

b

(001) Plane

Molecular arrangement in
(001)

Figure A.1 Raman spectra of three faces of an APAP single crystal at room temperature:
(a) Face 1, assigned to the (020) plane, shown in inset with corresponding arrangement of
the APAP molecules, (b) Face 2 assigned to the (20 1 ) plane with corresponding plane of
molecules in inset, and (c) Face 3 assigned to (001) with corresponding plane of
molecules in inset. Plane of each face is represented by red sheet. The “ball and stick”
convention of plane of atoms is used for acetaminophen molecule where grey, red, white,
and blue labels represent carbon, oxygen, hydrogen, and nitrogen respectively.
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Study of Single Crystal APAP as a Function of Temperature

The spectra were recorded with a confocal Raman system (for details see Chapter 2) as a
function of temperature using Linkam TS1500 heating and cooling stage at each of
following temperatures T = 25, 72, 101, 130, 154, and 175°C, Figure A.2 (a). The line
frequencies, particularly those associated with translational modes at low frequency
broaden and decrease in frequency with softening of the lattice as the temperature rises
from 25°C to near melting at 175°C, as shown in Figure A.2 (b). Shift in frequency is
also noticed for the C=O stretch at 1649 cm-1 which is associated with the intermolecular
type B hydrogen bonding discussed in section 3.4 and shown in Figure A.2 (c). As the
temperature rises, the line experiences some broadening with upshift in the peak position
of 2 cm-1, as shown in Figure A. 3 (a) and A. 4, respectively. Interestingly, even at
temperature values close to melting, (T = 175°C), the linewidths remain relatively narrow
indicating the presence of ordered intermolecular interactions. Slight change in the peak
position is most likely due to small local reorientations of the molecules upon heating,
resulting in the decrease of type B hydrogen bonding and increase in force constant for
the C=O stretching mode. Larger shifts in the frequency value can indicate transition to
the type III or amorphous phase as shown in Table 3.1. However, recorded changes in
peak position and associated peak broadening at close to the melting temperature, show
no significant amorphous behavior since the heating causes significantly smaller shift,
less than 9 cm-1, observed for the amorphous phase. Figure A.2 (c) and (d); and Figure
A.3 (b) and (c), show changes in peak positions and line broadening due to onset of
disorder, Figures A. 4, for lines at 3083 cm-1 and 3326 cm-1 associated with C-H and N-H
stretching modes respectively, show the largest changes with temperature. As indicated in

131

Table 3.1, the C-H vibration of the phenyl ring increases in frequency in the type III
polymorph of APAP and also in the amorphous phase. Upon heating, however, a
downshift by 3 cm-1 is observed indicating changes in local inter-molecular potential. By
contrast, at 175°C, the NH-stretching line at 3326 cm-1 upshifts by a surprisingly large
value of 12 cm-1 and broadens significantly. The influence of type A hydrogen bonding
on the N-H stretching vibration is therefore significant and shows large local changes in
symmetry around this bond indicating a strong driving force for polymorph formation. It
would therefore be interesting to study the spectra also as a function of stress in different
directions in order to see if polymorph formation is induced.
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(b)

(c)

(d)
1649cm-1

3083cm-1

3326cm-1

(a)

Figure A.2 (a) Raman spectra of APAP single crystal, face 1, taken as a function of
temperature at 25°C, 101°C, and 175°C show expansion of boxed regions: (b) 100 to 450
cm-1, (c) 1550 to 1750 cm-1, (d) 2850 to 3300 cm-1.

133

(a)

(b)

(c)

Figure A. 3 Evolution of peak frequencies in APAP single crystal with temperature for:
(a) 1648 cm-1 C=O stretching line, (b) 3083 cm-1 aromatic C-H asymmetric stretching
line, and (c) 3326 cm-1 N-H stretching line.
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(c) 3326 cm-1

(b) 3083 cm-1

(a) 1648 cm-1

Figure A. 4 Evolution of peak broadening with temperature for: (a) 1648 cm-1 C=O
stretching line, (b) 3083 cm-1 aromatic C-H asymmetric stretching line, and (c) 3326 cm-1
N-H stretching line.
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